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    RNA interference (RNAi) mediates potent antiviral response across kingdoms. In 
Caenorhabditis elegans nematodes, antiviral RNAi requires a virus sensor that is 
conserved in mammals and is amplified by secondary small interfering RNAs that are 
produced in a Dicer-independent manner. 
    To better understand worm antiviral RNAi, I carried out a biased genetic screen, aiming 
to identify novel antiviral RNAi genes. To speed up the gene discovery process, the 
reporter worms used for this genetic screen were engineered to contain extra copies of 4 
known antiviral RNAi genes. Therefore, genetic alleles derived from these 4 genes will be 
automatically rejected during screening process.  Since a viral replicon transgene was used 
as reporter for loss of antiviral RNAi my genetic screen was expected to identify genes 
required for antiviral RNAi but not artificial double-stranded RNA (dsRNA) triggered 
RNAi. 
    My genetic screen identified altogether 25 candidate alleles that appear to have derived 
from 13 candidate genes. Through genetic complementation tests and coding region 
sequencing I confirmed that 2 of the candidate genes are known antiviral RNAi genes rde-
3 and rrf-1. Of the rest 11 candidate genes, 9 were found not to be required for classical 
RNAi. Interestingly, Orsay virus infection assay further suggested that 7 of these 9 
candidate genes are dispensable for antiviral RNAi against Orsay virus. Since Orsay virus 
specifically infects intestine cells which have much weaker antiviral activity I believe that 
these 7 genes mainly function in non-intestine cells.  
    Through whole genome sequencing I identified 2 of the candidate genes as rsd-6 and 
mut-16, 2 known genes required for artificial dsRNA triggered RNAi. Currently, rsd-6 and 
mut-16 are not known to play a role in antiviral RNAi. Thus, my genetic screen, for the 
first time, identified both rsd-6 and mut-16 as key components for antiviral RNAi. 
1 
 
CHAPTER 1: GENERAL INTRODUCTION 
1.1 Caenorhabditis elegans  
 
    C. elegans is a type of round worms in nematode phylum. The C. elegans adults are 
typically 1 mm in-length. They feed on bacteria, usually the E. coli species [10]. C. 
elegans can be easily maintained in the lab by growing on agar seeded with bacteria food 
[11].  
 
The basic anatomy of C. elegans includes mouth, pharynx, intestine, and gonad. C. 
elegans has two sexes: hermaphrodites and males [12]. Hermaphrodites have two ovaries, 
oviducts, spermatheca, and a single uterus [12], while males have a single gonad, a vas 
deferens, and a fan tail for mating (Fig 1). 
 
    C. elegans has five pairs of autosomes and one pair of sex chromosomes [12]. 
Hermaphrodite C. elegans has a pair of sex chromosomes (XX), but the males have only 
Fig 1. Anatomical features of an adult C. elegans hermaphrodite (top) and male (bottom) [1].  
They all have mouth, pharynx, gonad, intestine. The major differences between hermaphrodites 
and males is that males only have one single-lobed gonad and a specialized fan tail for mating. 




one sex chromosome (X0) [12]. Hermaphrodites can be maintained by self-fertilizing. 
Males are able to be produced by heat shock at 42 °C for 40-45 minutes and maintained 
by crossing with hermaphrodites. Self-fertilized hermaphrodites can lay approximately 
300 eggs and the number can be above 1, 000 when fertilized by a male [12]. 
    At 20 °C, C. elegans has an average life span of 2-3 weeks, and it needs around 14 
hours, 12 hours, 8 hours, 8 hours, 10 hours, and 8 hours respectively to grow up from 
embryo, L1, L2, L3, L4-young adult to adult worm. In some extreme environments, such 
as food limitation, L1 larva can enter the dauer stage in which animals can survive 
without food for several months. After the stresses disappear, the dauer larva can directly 
develop into L4 larva [13, 14]. 
 
 
Fig 2. Life cycle of Caenorhabditis elegans grown at 25°C on agar plates seeded 
with Escherichia coli. Eggs are laid ∼5 h after fertilization, and hatching occurs ∼9 h later 
growing up from L1 to L4 in normal condition. L1 Larva can become dauer larva in extreme 
environment and develop to be L4 larva after the stresses disappear. (From Jorgensen and 





The genomic sequence of C. elegans was sequenced and published in 1998 with  the 
remaining gaps being finished by 2002 [15]. The C. elegans genome sequence is 
approximately 100 million base pairs long and  encodes around 20000 genes [10].  
 
1.2 C. elegans as model organism for research 
The establishment of Caenorhabditis elegans as a model system for fundamental 
biological research began in 1963 by Sydney Brenner in Cambridge. In a letter to Max 
Perutz, Brenner states that “future of molecular biology lies in the extension of research 
to other fields of biology, notably development and the nervous system.”  
There are six major reasons for using C. elegans as a model organism for research. (1) 
It is a small animal that contains orthologs and homologs of numerous human genes. 
Thus, mechanistic studies of C. elegans genes and pathways may have direct input to our 
understanding of human genes and related pathways. (2) It has very short life cycle (2-
day developmental process from embryo to adult), which can significantly expedite 
research progresses. (3) C. elegans is very easy to maintain in the lab at low cost so even 
labs with limited resources and personnel can use it for research. (4) The worm strains 
can be safely stored at -80°C with freeze buffer. It is thus not necessary to maintain live 
stocks in the lab. (5) Transgenic C. elegans strains can be created rapidly through 
injection of target plasmid constructs into the gonads followed by picking up the 
progenies with expected phenotype [16]. (6) C. elegans  loss of function mutants can be 
created through treatment with chemical mutagen, such as Ethyl Methanesulfonate 
(EMS), or exposure to ionizing radiation, such as UV light or gamma ray [4, 17]. Genetic 




back crossing, the worms are allowed to self-fertilize to become homozygotes for the 
target gene. At present, there is a large collection of C. elegans genetic mutants in 
Caenorhabditis Genetics Center (CGC). Or you can always request mutant strains from 
the labs that generated them [18]. 
 
1.3 RNA interference and gene silencing 
The phenomenon of gene silencing was first described in plants by Matzke and her 
colleagues.  They reported that the selectable marker encoded by a transfer DNA (T-
DNA) became silenced upon secondary transformation using the same T-DNA [19]. In 
1990, Napoli’s lab engineered transgenic plants harboring copies of flower pigmentation 
gene chalcone synthase (CHS). The plants are expected to overexpress CHS and 
strengthen the purple coloration in flowers. However, the transformed flowers showed 
different patterns of pigmentation, including white and purple with white, suggesting 
gene silencing of CHS in the transgenic plants [20]. At the same year, co-suppression 
phenomenon was also observed in plants which were engineered to express virus coat 
protein (CP). The transgenic plants confer resistance to corresponding virus or closely 
related viral strain [21]. In another study in 1993, Linbdo and colleagues also obtained 
Tobacco Etch Virus (TEV) resistance by transforming TEV sequence into the plants. 
They noted that the transgenic tobacco is resistant to TEV infection but  susceptible to 
unrelated virus strain Potato Virus X (PVX) [22]. Their nuclear run-off analysis and 
northern blot results showed that the TEV are still transcribed but mRNA cannot 
accumulate, indicating that gene silencing or co-suppression occurred in cytoplasm in a 




further confirmed this hypothesis. In their study, plants recovered from first infection by 
Tomato black ring nepovirus (strain W22) became highly resistant to W22 when the 
second infection was performed. However, the recovered plants were sensitive to 
infection of PVX virus, which is unrelated to W22. To find out whether it is the sequence 
similarity between W22 and PVX virus that accounts for such a phenomenon, PVX virus 
was engineered to carry W22 sequences and then was used for the secondary infection 
[23]. As a result, the mRNA of the modified virus failed to accumulate in plants, 
suggesting the existence of sequence-specific antiviral gene silencing in a transgene-
independent manner. 
 
1.4 RNAi and dsRNA trigger in C. elegans 
    Although the phenomenon of gene silencing was first found in plants, the discovery of 
double-stranded RNA as trigger to induce gene silencing was made later by Andrew Fire, 
Craig Mello and their colleagues by utilizing C. elegans as model organism. They found 
 
Fig 3. Illustration of RNAi triggered by dsRNA. The difference forms of RNA were 
introduced into worm gonads by injection. There is no effect while injecting sense 
RNA or antisense RNA, whereas injecting double-stranded RNA induced strong 




that injecting sense and antisense RNA molecules encoding a muscle protein led to no 
effect in the movement of C. elegans. However, the worm lost the function of the same 
gene after injecting corresponding double-stranded RNA (Fig 3) [24]. They characterized 
several features of the RNA interference (RNAi) phenomenon: (1) it is only induced by 
dsRNA, (2) the effect of RNAi is systemic, and (3) RNAi is heritable. This discovery 
significantly speeded up studies on RNAi in plants and fungi and the study on 
endogenous RNAi regulated by miRNAs (microRNAs) which were discovered 
previously. In the siRNA (small interference RNA) -mediated RNAi pathway, RNAi 
response is triggered by dsRNA [24-27]. dsRNAs will be then cleaved by Dicer proteins 
into short 20 to 30 nucleotides (nt) RNA duplex named siRNAs [28, 29]. The passenger 
strand is then degraded, and the guide strand will be incorporated into the RNA-induced 
silencing complex (RISC) to target transcripts through complementary base pairing, 
resulting in either degradation or translation block. In some organisms, such as plants and 
C. elegans, RNA-dependent RNA polymerases (RdRPs) produce secondary siRNAs to 
amplify RNAi response [30-32]. Therefore, RNAi in these organisms is very efficient 
despite limited amount of primary siRNA being produced. In addition, some organisms 
have structure channels such as plasmodesmata in plants or protein transporter like SID-1 
protein in C. elegans, leading to the RNAi signal spread from cell to cell [33, 34]. The 
capability to help RNAi response spread systemically contributes to efficient antiviral 







1.5 Molecular mechanisms of worm RNAi 
    Classical RNAi is defined as initiating RNAi response using artificial double-stranded 
RNA. Originally, RNAi study was conducted by injecting dsRNAs into worm gonad or 
cavities to induce the phenotype  in parents or progenies [24]. Later, Lisa Timmons and 
Andrew Fire developed a construct which can produce dsRNA in E. coli. After they 
transformed the engineered construct into E.coli and fed worms with it, the corresponding 
gene was successfully silenced [36]. At the same year, Tabara and Mello proved that  
soaking worms in dsRNA is also able to trigger the silencing of homologous genes [37] 
(Fig 4).  
    Based on these discoveries, Tabara and Mello performed large-scale random genetic 
screens to look for genes required for RNAi. After mutagenesis, only RNAi deficient 
mutants can produce normal brood of viable progenies while one of the genes important 
 
Fig 4. Illustration of strategies for triggering RNAi in C. elegans. (A) Feeding the worms with 
transgenic bacteria expressing dsRNAs to silence the corresponding gene of interest. (B) 
Transgenic array producing specific dsRNAs in vivo. (C) Synthesized dsRNAs introduced 





for embryogenesis is silenced through dsRNA feeding method. The mutants identified in 
this study were termed RNAi-deficient (rde) mutants [38]. Among the genes they 
identified rde-1 (RNAi defective 1) encodes an Argonaute protein. rde4 (RNAi defective 
4) encodes a dsRNA binding protein. Some other rde mutants, such as rde-2 and rde-3, 
exhibited high rate of transposon mobilization [38]. 
    Soon after that, the RNAi pathway was found to be conserved in diverse organisms. It 
is also widely applied in identifying the biological function of genes in cell culture or in 
model organisms through the RNAi-mediated “knockdown” strategy. Since RNAi may 
not completely abolish the expression of target genes, multiple repeats should be done to 
confirm the results. 
 
Fig 5. Extracellular long dsRNA is taken up by the intestinal cells via SID-2 RNA 
transporter. Long dsRNAs are processed into small dsRNA fragments known as primary 
siRNAs by the DICER/RDE-4 complex. One of strand from primary siRNA is loaded into 
RISC and guide it to its complementary targets. RdRP is recruited to generate secondary 
siRNAs (22GRNAs) by using primary siRNA as primers. (From Alper Akay, Peter Sarkies 




    Classical RNAi pathway is initiated by artificial dsRNAs of C. elegans genes. In the 
first step, the PAZ-PIWI family protein, RDE-1, and the dsRNA binding protein, RDE-4 
(RNA defective 4), together with worm DICER, DCR-1 (an RNase III family 
ribonuclease) [40] form a complex to process dsRNA into siRNAs (Fig 5) [41]. 
Subsequently one of the strands (anti-sense strand) is loaded into RDE-1-associated 
complex, RISC. However, there are around 25 PAZ-PIWI homologs in C. elegans [38]. 
Most of them act as components of RISC and the functions are still unknown. Guide 
strand from siRNA directs RISC to its complementary target transcripts and initiates 
post-transcription silencing (Fig 5). This process can be amplified by synthesizing 
secondary siRNA with the help of RNA-dependent RNA polymerase using target RNA 
as template.  
 
1.6 Gene silencing mediated by microRNAs  
    Discovery of classical RNAi pathway greatly facilitates the studies on endogenous 
RNAi in various organisms because both classical and endogenous RNAi share some 
core components such as Dicer. Loss of Dicer function results in lethality and sterility in 
C. elegans [42-44]. Another example is the RDE-4, a dsRNA-binding protein. It is 




Three main types of endogenous small RNAs, microRNA, endogenous small 
interfering RNA (Endo-siRNA), and piwi-interacting RNA (piRNA), were found  to play 
important roles in development across kingdoms [47, 48]. In C. elegans, miRNAs 
contribute to diverse development and physiological processes in soma cells. Endo-
siRNAs, also termed 22G and 26G RNAs, and piRNAs are required for germline 
development, transposon control, and pseudogene control. The major role of Endo-
siRNAs and piRNAs is to constitute a complete, robust system for controlling 
development activity of C. elegans (Fig 6).   
The first type of endogenous small RNA discovered in C. elegans is the miRNA lin-4. 
The study on the biological function of lin-4 suggests that small RNA can initiate post-
Fig 6. Biogenesis of the three endogenous classes of small RNAs. (left) endo-siRNAs can be 
produced by RdRPs using mRNAs as templates, or produced by Dicer thorough cleavage of 
long dsRNAs that are derived from convergent transcripts long-hairpin RNA and homologous 
pseudogenes. (center) pri-miRNAs are transcribed from miRNA genes and can form stem-
loop structure precursors. Pri-miRNAs are sequentially processed by RNase III enzymes 
Drosha and then Dicer to turn into mature miRNAs. (right) piRNAs are generated in a Dicer-
independent manner from long piRNA precursors, which are transcribed from piRNA genes or 
directly from piRNA cluster. piRNA is incorporated onto PIWI proteins. They can be 
amplified by PIWI family Argonautes in a ping-pong mechanism. (From Cecere G and 




transcription regulation [49, 50]. lin-4 is required for L1-L2 stage transition during 
development [51]. This means that lin-4 directed worm development is to regulate lin-14, 
which encodes protein required for specifying division timings. Previous studies proved 
that lin-4 binds to the 3’ untranslated region (UTR) of Lin-14 with imperfect 
complementarity for negative regulation [49, 52].  
The second microRNA identified was let-7, whose sequence is conserved in 
drosophila, zebrafish and humans. In C. elegans, let-7 controls L4-adult transition by 
down-regulating lin-41, which encodes a protein required for specific postembryonic cell 
fate [53, 54]. let-7 interacts with lin-41 at two sites in its 3’UTR region [54]. These let-7 
complementary sites are also found in drosophila and zebrafish in 3’UTR of lin-41 [55], 
suggesting this mechanism is also conserved in other animal species. Since the discovery 
of the first two miRNAs, the role for miRNAs in development has been established and 
more and more miRNAs were identified in C. elegans. For example, lsy-6 and mir-273 
are two miRNAs involved in controlling asymmetric fates of two neurons in the head 
[56]. It is important to note that miRNAs also play very important roles in mammals 
because the activity of up to 30% of the proteins is controlled by miRNAs in mammals 
[57]. In total, 88 validated miRNA genes are found in the C. elegans and almost half of 
them are conserved in humans [58].  
In C. elegans, the miRNA biogenesis begins with the transcription of primary miRNA 
(pri-miRNA) by polymerase II [59]. Pri-miRNA is then cleaved by the endonuclease III 
Drosha together with partner of Pasha into precursor-miRNA (pre-miRNA) [60]. The 
Pre-miRNA is exported from the nucleus to the cytoplasm in an exportin-5-protein-




protein Dicer in cytoplasm, generating a short imperfect double-stranded miRNA duplex. 
One of the strands is selected and incorporated into RISC [62], which is a complex 
containing the Argonaute family protein [63].    
1.7 RNAi and antiviral immunity in diverse organisms 
 Viruses are formidable pathogens for all living organisms. These intracellular 
pathogens interact with their host cells and hijack the machineries for replication. As a 
result, hosts evolve resistance pathways against viruses. 
    Antiviral defense is one of the natural functions of RNA interference [64-67]. In 
insects, it is known that RNAi is the major antiviral pathway that contains Dicer, DCR-2 
and Argonaute protein family. In insects several viral recognition and antiviral signaling 
pathways have been identified. For instance, insects have three orthologues of eIF2α 
kinases, which control translation initiation of viral replication in mammals. As another 
example, the JAK/STAT and Toll signaling pathway are found to have antiviral activity 
in insects. These two signaling pathways are used to transmit signals to the nucleus, 
leading to the expression of proteins against virus [68, 69]. Another strategy in insects to 
control the viruses is cell death, which prevents virus from spreading out by killing virus-
infected cell.  
 Fungi have evolved essential antiviral mechanism mediated by RNAi. Fungi have two 
Dicer-like proteins (DCL-1/2) and three Argonaute proteins (QDE-1/2/3). Virus-derived 
dsRNA can trigger RNAi response under the control of Argonaute protein QDE-2 and 
DCR-2, together with other homologs of antiviral genes [70].  
      In plants there are four Dicer-like (DCL) proteins. MicroRNAs are predominantly 




endogenous siRNAs. In plants antiviral defense against RNA viruses are also processed 
by DCL4, DCL2 and DCL3. Viral double-stranded RNA are cleaved by these DCL 
proteins into primary 21 to 24 nt virus-derived small interfering RNA (viRNA) based on 
viral structure in a hierarchical manner [66, 71, 72]. Plant Argonaute proteins also 
participate in antiviral RNAi. Previous study showed that AGO1, AGO2 and AGO7 
appear to contribute to RNAi-mediated antiviral responses [73-76]. Plant AGOs associate 
with viRNAs to target complementary viral RNA. The AGOs can initiate viral RNA 
degradation in three ways. The first is through their slicer activity or translational arrest 
of AGOs. The second is to transcriptionally repress viral gene expression by DNA 
hypermethylation (For DNA virus) [77]. The third is to promote host gene expression for 
viral defense [78]. In addition to primary viRNAs processed by DCLs and AGOs, RdRPs 
are able to amplify plant antiviral response by producing viral secondary siRNAs [79-81]. 
In vertebrates, dsRNA and siRNA are known to initiate the transcription-based 
antiviral interferon (IFN) response [82, 83]. At the beginning, viral ssRNA (single 
stranded RNA) and dsRNA is recognized by viral sensors such as Toll-like receptor, 
RIG-I (retinoic acid inducible gene I)-like receptor and the dsRNA-dependent protein 
kinase R (PKR). The binding between viral sensor and virus dsRNA leads to activation of 
the IFN-regulatory transcription factors (IRF) and NF-κB. As a result, IFNs expression is 
activated. IFNs then give rise to the transcription and expression of IFN-stimulated genes 
(ISGs) through the JAK-STAT signaling pathway for antiviral activity [82, 84-86]. 
Although some recent studies demonstrated that RNAi in nascent mammalian cells has 
potential activity against RNA viruses, IFN response is still believed to  play the major  




1.8 Current understanding of antiviral RNAi in C. elegans 
      C. elegans has been shown to be an ideal model to study RDVI (RNAi-derived Viral 
Immunity). More importantly, RNAi is the major antiviral defense for C. elegans, making 
the study of RDVI mechanism much easier and straight-forward compared to other 
organisms such as insects and mammals, in which multiple antiviral pathways co-exist.  
    In C. elegans, infecting viruses, usually single stranded, generate long dsRNAs during 
replication. In plants and invertebrates, Dicer cuts viral dsRNAs into small fragments of 
viRNAs, which are structurally similar to the siRNA duplex intermediate [64]. This 
process is conducted by DCR-1, the only Dicer protein in C. elegans. Afterward, one of 
the strands, termed as guide strand, from the viRNA duplex is loaded into RISC and used 
 
Fig 7. Schematic pathway of RDVI. Under the low concentration of viral dsRNA, viral 
dsRNAs are more likely to be detected by DRH-1 and RDE-4 and cleaved by DCR-1. When 
the viral dsRNA concentration is very high, the viral dsRNA can be processed by DCR-1 in 
the absence of RDE-4. The subsequent processes are the same. One of the strand from 
primary siRNA, guide strand, will be loaded into RDE-1 complex as a sequence guide to 
target viral mRNA. This process can be amplified by producing secondary viRNAs with 
RRF-1 (RdRP), DRH-3 and RSD-2. Secondary viRNAs bind to secondary WAGO to initiate 




as reference to target viral transcripts through complementary base pairing, leading to the 
silencing of viral gene expression [87]. In some organisms, such as plants and nematodes, 
the production of secondary siRNAs generated by RdRP amplifies antiviral RNAi 
process by engaging the secondary worm-specific AGO (WAGO) proteins [80, 88].  
    Our studies suggest that RDVI can proceed in two pathways. One is RDE-4 dependent 
pathway which defends against low concentration of viral dsRNA. The other one is RDE-
4-independent pathway when high concentration of viral dsRNAs are produced in the 
organism (Fig 7). In these two pathways, the downstream processes following the 
production of primary siRNA are believed to be the same. One of the crucial domains of 
RDE-1 has an RNase H like activity that performs a cleavage on the target RNA 
molecule [89, 90]. However, the “slicer” activity from RDE-1 is unlikely to cleave 
mRNA, but to cleave primary siRNA duplex [91]. During the amplification process, 
recruitment of RdRP (RRF-1) initiates the de novo synthesis of secondary viRNAs using 
the viral mRNA as template [7]. In the meantime, RSD-2 (RNA spreading defective 2）
and DRH-3 are also involved in maintaining the functionality of secondary viRNAs [92]. 
Unlike primary siRNAs, secondary siRNAs are single-stranded and contain a 
triphosphate group at the 5’ end [31, 32]. These secondary siRNAs bind secondary 
WAGO proteins and  destroy viral RNAs through an unknown mechanism [93].  
Detailed information about the genes associated with known antiviral RNAi pathway 





1.8.1 The drh-1 Gene 
    DRH-1 (Dicer-related helicase 1), RNA helicase-related protein, was first found in a 
protein complex with RDE-4, DCR-1, RDE-1 in vivo. DRH-1 is not required for classical 
RNAi since drh-1 mutant is still sensitive to RNAi feeding. 
    C. elegans encodes a family of Dicer Related Helicases (DRH), including DRH-1, 
DRH-2 and DRH-3. They all contain a DExD/H box RNA helicase domain highly 
homologous to DICER and the mammalian RIG-I-like RNA helicase (RLH) family 
composed of RIG-I, MDA5 and LGP2 [6, 27, 28]. These RLH proteins possess the ability 
to recognize nucleic acid signatures from virus and initiate activation of antiviral 
signaling pathway.  
There are no developmental abnormalities observed in drh-1 mutants. In recent study, 
DRH-1 was shown to function in RNAi-mediated antiviral immunity in C. elegans. It 
encodes the helicase and C-terminal domains homologous to the mammalian RIG. It is 
been reported that the complete antiviral function of DRH-1 requires both RIG-I 
homologous domains as well as its worm specific N-terminal domain [94]. In addition, 
C-terminal domain and helicase domain encoded by human RIG-I can functionally 
substitute corresponding domains in DRH-1 [3]. What’s more, northern blot and small 
RNA deep sequencing analysis indicate that DRH-1 acts to enhance production of viral 
primary siRNAs but not secondary siRNA [3]. These results thus revealed that DRH-1 
plays an essential role in antiviral defense mechanism mediated by RNAi. Similar to 
human RIG-I, DRH-1 is very likely to function as viral sensor and facilitate acquisition 
of viral dsRNA. Interestingly, another study from Dr. Ding’s lab suggested that DRH-1 




on the viral long dsRNA precursors. Their hypothesis is based on different distribution of 
viRNA “hot spots” in between drh-1 mutants and wild type animals [95]. 
 
1.8.2 The rsd-2 Gene 
    RSD-2 is a novel protein with no close homologs in other species. Originally, rsd-2 
was identified as a gene required for RNAi spreading from somatic cells to germline cells 
in C. elegans. rsd-2 mutants show no developmental defects [96]. Studies have shown 
that rsd-2 mutants displayed a phenotype when fed with dsRNA against somatic genes, 
but not germline genes [96]. These findings indicate that rsd-2 mutants are sensitive to 
RNAi against somatic genes, but not to RNAi targeting germline genes. In other words, 
mutations in the rsd-2 gene do not affect somatic RNAi [96]. 
    Later on, it was discovered that the function of rsd-2 in RNAi is very complex and 
environment-related. Firstly, rsd-2 gene mutants are mosaic with respect to somatic 
RNAi and germline RNAi based on the observations that some of the cells are RNAi 
defective (somatic and intestine) but some are not (germline). Secondly, the rsd-2 
mutants show environmentally sensitive defects. For example, temperature sensitivity. 
Moreover, rsd-2 mutants have a dosage-sensitive nature, in other words, higher dosage of 
dsRNA can elicit better RNAi response in rsd-2 mutant. Additionally, rsd-2 also plays an 
important role in chromosome integrity, such as transposon silencing [67]. 
The rsd-2 gene is located on chromosome IV and is predicted to encode three copies of 
N-terminal domain at the N terminus [96]. RSD-2 protein was found to exist in multiple 
cellular compartments, including the nucleolus and cytoplasm, and to most frequently 




accumulation of X-cluster (a region of the X chromosome from which abundant 22Gs) 
22G RNAs [97], suggesting a critical role in WAGO 22G RNA accumulation or function. 
Study from our lab also demonstrate that rsd-2 is responsible to biogenesis of secondary 
viRNAs [7]. 
 
1.8.3 The rde-1 Gene 
The rde-1 gene was identified in a large-scale genetic screen. Several other rde 
mutants such as rde-4, rde-2 and rde-3 were also identified in the same genetic screen 
[37].      
rde-1 is a member of the AGO gene family conserved in numerous organisms. 
Members of the AGO family are involved in developmental pathways in insects, fungi, 
plants and animals. RDE-1 is composed of four domains: A N-terminal domain, a PAZ 
domain binding to 3’ of guide RNAs, a MID domain forming the structure for 5’ of guide 
RNA binding, and a piwi domain with endo-nucleolytic activity [98]. It is known that 
RDE-4 interacts with RDE-1 and DRC-1 in the exogenous RNAi pathway. The 
interactions among these proteins result in a transfer of siRNA from RDE-4/DCR-1 
complex to RISC containing RDE-1 [40]. However, Secondary 22G siRNAs are rarely 





1.8.4 The rde-4 Gene 
    RDE-4 interacts with dsRNA in vitro and in vivo. The RDE-4 protein contains two 
copies of dsRNA binding motif (dsRBM) that is also found in numerous other proteins. 
The dsRBM interacts with dsRNA in a sequence-non-specific manner [99]. In reciprocal 
assays, RDE-1 and RDE-4 were found to co-precipitate, suggesting a stable interaction 
between RDE-4 and RDE-1 in vivo. RDE-4 protein also interacts in vivo with DCR-1 and 
a conserved DExH-box helicase DRH-1 [40]. 
      Previous study showed that DRH-1 and RDE-4 function in the upstream of the 
initiation of RNAi (Fig 8) [100]. RDE-4 does not appear to interact with mRNA or 
siRNA. The RNA sequence bound to RDE-4 are strictly within the dsRNA trigger [40]. 
The  interaction between RDE-4 and Dicer in the RDE-4 immune complex allows RDE-4 
to present the foreign trigger dsRNA to DCR-1 for processing [40]. 
 
Fig 8. Northern blot analysis of viRNA in different antiviral RNAi defective mutants under 
long exposure (upper) and shorter exposure (bottom). No viRNAs were detected in drh-1 and 
rde-4 mutants. In comparison, viRNAs accumulation are found in both rde-1 and drh-3 





1.8.5 rrf-1 and drh-3 
rrf-1, which encodes an RNA-dependent RNA polymerase, is responsible for most of 
the RdRP activity in exogenous RNAi in somatic cells [88]. DRH-3, a worm RIG-I like 
homolog shares a similar domain structure with DRH-1 but confers distinct function. In 
northern blot assay (Fig 8) and deep sequence results (Fig 9) of viRNAs, rrf-1 and drh-3 
mutants produced a typical 23 nt length population of primary viRNAs, but not 22 nt 
secondary viRNAs. These results strongly suggested that these two genes are required for 
the biogenesis of secondary viRNAs, but not primary viRNA. Therefore, both rrf-1 and 
drh-3 contribute to antiviral RNAi in the amplification stage. They play an important role 
in biogenesis and functionality of viral secondary siRNA.  
      In our study, drh-3 and rrf-1 mutants were used to check whether the transgenic array 
we developed can influence virus replication in the absence of rrf-1 or drh-3. 
 
 
Fig 9. The size distribution of virus-derived reads in rrf-1 and drh-3 mutant. Distribution of 
reads reveals a strong read bias at 23 nt length in both rrf-1 and drh-3 mutant worms. (From 




1.9 Objective of my research  
The aim of my study is to better understand how RNAi regulates virus-nematode 
interactions using C. elegans as a model system. Previously random large-scale genetic 
screens have been carried out to identify genes involved in classical RNAi [38]. 
However, the genes that specifically contribute to antiviral defense cannot be discovered 
this way. For example, drh-1, a gene not required for classical RNAi, was discovered 
through biochemical approach. By using modified-virus as a reporter of loss of RNAi, we 
are expecting to identify genes involved in both classical RNAi and antiviral RNAi. 
      C. elegans genome encodes RdRPs as do plant genomes. Like mammals the worm 
genome also encodes a single Dicer. Thus, findings from my study are expected to have 
 
Fig 10. The structure of transgene array. The  transgene array includes Psur-5::rde1::UTR, 
Psur-5::rde4::UTR, Psur-5::drh-1::UTR, Psur-5::rsd-2::UTR, HIP::RdRP::GFP and 
Pmyo2::mCherry::UTR. Psur-5, the promoter for the endogenous gene sur-5; rde-1, the 
coding sequence of wild-type rde-1; rde-4, the coding sequence of wild-type rde-4; drh-1, the 
coding sequence of wild-type drh-1; rsd-2, the coding sequence of wild-type rsd-2; UTR, the 
3’-end untranslated region of unc-54; Pmyo2, a pharyngeal muscle promoter which can only 





direct input to the study of RDVI in diverse organisms. My study on the function and 
mechanism of worm-specific genes is also expected to unravel some novel features of 
worm RDVI. 
      Currently, it remains unclear whether RDVI in C. elegans requires novel genes. 
Apparently, identification and function characterization of novel RDVI genes will allow 
us to gain further insight into the mechanistic basis of antiviral RNA silencing across 
kingdoms. Recently, RNAi as an antiviral mechanism was found to be active in 
pluripotent mammalian stem cells and essential for developing mice to fight against virus 
infection. Thus, a better understanding of worm RDVI may facilitate the development of 
novel therapeutic strategies for the treatment of human diseases caused by viral infection. 
      To identify novel genes involved in worm RDVI, we developed a unique reporter 
worm strain termed 48 that contains a viral reporter and four known antiviral RNAi 
genes. I mixed 6 plasmid constructs, corresponding to Pmyo-2::mCherry::UTR, 
HIP::FR1gfp, Psur-5::drh-1::UTR, Psur-5::rde-1::UTR, Psur-5::rde-4::UTR, and Psur-
5::rsd-2::UTR respectively (Figure 10), and injected them into rde-1;rde-4 double 
mutants that already contain an HIP::FR1gfp-derived transgene. The viral reporter 
transgene array will produce green fluorescence upon the loss of antiviral RNAi. In C. 
elegans, transgenes generated through gonad microinjection often exist in multiple 
copies. Thus, a genetic screen utilizing 48 as reporter will be unlikely to provide hits to 
any of those four known antiviral RNAi genes because of the redundant copies for each 
gene. We expect that a large scale genetic screen utilizing the 48 worms as reporter will 






CHAPTER 2: MATERIALS AND METHODS 
    This chapter describes the materials and experimental protocols in this study. Sample 
volumes up to 2.0 mL were centrifuged in Micro-Centrifuge Tubes with 
graduations(VWR), sample volumes from 2.0-14 mL were centrifuged in 14 ml 
Polypropylene Round-Bottom Tube (BD Falcon). Sample volumes larger than 14 ml 
were all centrifuged in 50mL Centrifuge Tube (Cristalgen). 
2.1 Materials 
2.1.1 Worm Strains 
   Caenorhabditis elegans strains used for the study: 
    N2, wild type of C. elegans was used as a reference strain in this study. N2 line is 
derived from the Bristol culture in the spring of 1964. 
    All other strains used in this study are derived from N2 and include rde-1(ne300), rde-
4(ne337), rsd-2(pk3307), drh-1(tm1329), rrf-1(ok589), drh-3(ne4253). 
    rde-1 (ne300) has a single nucleotide substitution causing a premature stop codon prior 
to the most conserved region within K08H10.7 product. 
    rde-4 (ne337) contains a nucleotide substitution which induces a premature stop codon 
at amino acid residue 229 of the T20G5.11 product. 
    rsd-2 (pk3307) contains a point mutation at position 13832 in chromosome IV (C to T) 
which induces a premature stop codon. 
    drh-1 (tm1329) has 483bp insertion at position 10039 and a 13bp insertion on 
chromosome IV. 
    rrf-1 (ok589) is a deletion allele which contains 910bp deletion that affect coding exon 




   drh-3 (ne4253) is a single base transition (C to T) at position 3896 on chromosome creating 
an early stop codon. 
The genotypes of rde-1, rde-4 and rsd-2 were confirmed by skn-1 feeding RNAi 
together with DNA sequencing. The genotype for drh-1 was confirmed by PCR. The 
worms were maintained in NGM (nematode growing medium) seeded with OP50 
bacteria. 48 transgene array and 11 transgene array were delivered into various genetic 
backgrounds by standard genetic cross. 46 transgene array was integrated onto genome of 
11/N2 background and then introduced into other different genetic backgrounds by 
standard genetic cross.  All the worm strains are grown up at 20-22℃. 
 
2.1.2 Bacteria strains 
    All feeding plates were seeded with bacterial strains, derived from HT115 (DE3), 
engineering to express double-stranded RNAs corresponding to target genes [101, 102]. 
This RNase III-deficient strain has an IPTG inducible gene which encodes T7 RNA 
polymerase. Because the DNA sequence is inserted between two T7 RNA polymerase 
promoters in the plasmid, the binding of T7 RNA polymerase to T7 promoters leads to 
the transcription of dsRNA from two strands of insert [103]. The vector is marked with 
Tetracycline resistance[104].  
    To introduce RNAi by feeding with dsRNA-expressing HT115, worms at L1 or L2 
larvae stage were transferred onto freshly prepared feeding plates.  
    DH5α competent cells are used for general cloning. The cells are defined by three 




blue white screening. Calcium chloride are often used to help transform plasmids into the 
cell. 
    Plates containing OP50 food were used as control in each experiment. E. coli OP50 is 
an uracil auxotroph whose growth relies on the nutrients of NGM plate. The limited 
bacteria growth is desirable because it can offer easier observation and operation. 
All the bacteria were grown at 37℃ overnight. Liquid cultures were grown in a shaker 
at 180 RPM (NEW BRUNSWICK SCIENTIFIC). 
 
2.1.3 Virus 
    There are two viruses included in our study, Flock House Virus (FHV) and Orsay 
virus. 
    FHV is a positive-stranded RNA virus isolated from Costelytra Zealandica (white). 
The FR1gfp replicon (HIP::RdRP::GFP) was developed from flock house virus (FHV) 
RNA1 by replacing the coding sequence of B2, the FHV-encoded RNAi suppressor, with 
green fluorescence protein (GFP) sequence. 
Orsay virus is a positive single-strand RNA virus that naturally infects C. elegans 
nematode. The virus was discovered in rotting fruit in Orsay, France. The virus was 
maintained in worm strain JU1580.  
 
2.1.4 Transgene construction 
All plasmids constructed for constitutive expression of the target genes were based on 
the PD51 vector described previously. Transgene array including Psur-5::rde1::UTR, 




Myo2::Mcherry::UTR. Psur-5, the promoter for the endogenous gene sur-5; rde-1, the 
coding sequence of wild-type rde-1; rde-4, the coding sequence of wild-type rde-4; drh-
1, the coding sequence of wild-type drh-1; rsd-2, the coding sequence of wild-type rsd-2; 
UTR, the 3’-end untranslated region of unc-54. It is noted that besides Psur-5::rde1::UTR 
and Psur-5::rde4::UTR, the other four constructs (Psur-5::drh-1::UTR,  Psur-5::rsd-
2::UTR, Pmyo2::mCherry, HIP::FR1gfp) are already available in our lab before this 
project. 
 
2.1.5 Nematode growth media (NGM) plates and LB agar plates 
    NGM plates preparation starts with making potassium phosphate (PPK) buffer prior to 
making NGM plate by mixing 132 mL of K2HPO4 (1 M) with 868 mL of KH2PO4 (1 
M).  For 1 liter of NGM, dissolve 2.5g NaCl, 3g bacto peptone and17 g/L agar in 975 ml 
purified water. After autoclaving, add 1mL 1M CaCl2, 1M MgSO4, 0.5 ml 10mg/ml 
cholesterol, 25 mL PPK and 15 mL 2g/L Uracil when the agar cools to around 65℃. 
    LB agar plates were prepared by mixing 20/L Agar, 10g/L Tryptone, 10g/L NaCl and 
5g/L Yeast Extract. Add 1L deionized water and sterilize by autoclaving. Add 100 µg/mL 
ampicillin if needed when agar is cooled to 50 ℃. 
 
2.1.6 Imaging Microscopy  
GFP fluorescence images were collected using an AmScope MT1000 camera mounted 






2.2.1 Infectious Filtrate Preparation and Orsay Virus Inoculation 
    Orsay virus was maintained using the JU1580 strain at 20℃ feeding on normal OP50 
E. coli bacteria. To prepare infectious Orsay virus filtrate, infected JU1580 worms were 
washed off from 10 cm plates using autoclaved distilled water. The virus-containing 
liquid was then filtered through 0.22-μm filter units and mixed with OP50 culture or 
other H115-derived strains for NGM plate seeding.  
2.2.2 Transgenic Construct and Transgenic Worms 
    To develop such a reporter worm strain, I mixed 6 plasmid constructs, corresponding 
to Pmyo-2::mCherry, HIP::FR1gfp, Psur-5::drh-1::UTR, Psur-5::rde-1::UTR, Psur-
5::rde-4::UTR, and Psur-5::rsd-2::UTR respectively（developed from PD51 vector）, 
and injected them into rde-1;rde-4 double mutants that already contain an HIP::FR1gfp-
derived transgene (developed from PPD49_83 vector by Fire Lab C. elegans Vector Kit 
1995). The Pmyo-2::mCherry-derived transgene is expected to direct mCherry expression 
only in the head of transgenic worms, and thus will serve as selection marker for the 
transgene array to be created. The HIP::FR1gfp-derived transgene will serve as viral 
reporter in this study as it will initiate virus replication and GFP production upon heat 
induction. Transgenes derived from the other four constructs will direct the expression of 
drh-1, rde-1, rde-4 and rsd-2 respectively. Heat induction was performed at 33℃ for 3 
hours. The heat induced plates were then incubated at 25℃. Assays were performed 24 to 






Microinjection is an effective method to create transgenic strain in worm system. Since 
the distal gonad of C. elegans contains a central core of cytoplasm that is shared by many 
germ cell nuclei. Therefore, delivering DNA at this position will have the most chance to 
generate transgenic progenies. The extrachromosomal DNA arrays usually form by using 
this technique. I use capillary tube and pull needles for microinjection. The final 
concentration of DNA injection mix should be 200 ng/µL (60% 1kb DNA ladder, 10% 
reporter gene, 10% transgene, 20% PUC18 vector). Centrifuge DNA mix for 10 min at 
max speed. This pellets any dust particles in the tube, which may block the needle. Load 
1 µl of DNA injection mix to the unpulled end of capillary tube and wait for at least 
10min until all the DNA solution move to the tip of the needle. Break a small opening of 
the needle by gently hitting the needle to a capillary tube. Lay C. elegans on agarose pad 
and cover them with microinjection oil to prevent them from dehydration. Find the gonad 
of C. elegans, position the worm at the orientation of 30º to 45º towards the needle. Insert 
the needle into the worm gonad and inject DNA solution (Fig 11). 
 
Figure 11. Microinjection of the C. elegans gonad. The optimal position of the injection 
needle in the cytoplasmic core of the distal germ line is depicted. For DNA transformation, 
injection solution should flow in both directions through both the distal and proximal germ 






2.2.4.1 Preparation of competent cell 
    Grow up the cells (DH5α, HT115) on the LB plates at 37oC overnight. Place one 
colony in 500ml LB media and grow overnight at 37 oC. Stop incubation when the E. coli 
is at an OD600 between 0.4 and 0.6 and place it on ice. Transfer cells to centrifuge bottles 
and centrifuge at 4 oC for 3500rpm for 15 mins. Discard supernatant and resuspend in 
0.1M CaCl2 and 15% glycerol. Cells must remain cold in all the procedures. The 
competent cells were stored at -80oC in 100 µl aliquots.  
 
2.2.4.2 Transformation 
    Mix 10pg-150ng DNA with 100 µl competent cells, and incubate on ice for 30 mins. 
Heat shock at 42 oC for 45 secs and then place cells on ice for 5 mins. Then suspend the 
competent cells with 400 µl of LB media and incubate in a shaker at 37 oC at 180rpm for 
45 mins. Place the cells on LB plates containing antibiotics and allow it to grow up at 37 
oC overnight. Only transformed cells can survive the next day. 
 
2.2.5 Plasmid extraction  
    DNA plasmid extraction method is modified based on protocols from QIAGEN 
plasmid kit. Harvest bacterial culture (100 mL) overnight at 37 oC. Centrifuge bacteria at 
3500rpm for 15 min. Discard supernatant and resuspend the bacterial pellet in 4 ml buffer 
P1. Add 4 ml Buffer P2, invert to mix and incubate at room temperature for 5 min. Add 4 
ml Buffer P3, mix well and incubate on ice for 15 mins. Transfer the solution into 14 ml 




QBT and allow the column to empty by gravity flow. After centrifuge the bacterial 
solution, transfer the supernatant of bacterial solution to QIAGEN-tip and let it flow 
through the column. Wash the QIAGEN-tip with 10 mL buffer QC two times. Elute DNA 
with 5 ml Buffer QF and add 3.5 mL of isopropanol for precipitation. Centrifuge at 
14000rpm for 30 min at 4 oC and a white pellet is expected to form at bottom of tube. 
Wash the DNA pellet with 2 ml of 75% ethanol and centrifuge at 14000 rpm for 5 mins. 
Air dry the pellet for 5-10 mins and dissolve DNA with appropriate volume of pH 8.0 TE 
(Tris-EDTA) buffer. 
 
2.2.6 RNA Extraction 
    Wash worms off plates with M9 buffer or RNAase free water and collect them in 15-
ml Corning tubes. Wash 2 – 3 times to get rid of bacteria. Add 1ml Trizol reagent and use 
homogenizer to break C. elegans. Add 0.2 volume of chloroform and Invert 5-6 times, 
and let sit 2-5 min at RT (room temperature) for phase separation. Transfer the solution 
into phase-lock gel tube and Spin 15 min at 12,000 x g at 4 °C. RNA is in the aqueous 
supernatant. Transfer top supernatant to new RNase-free tube. Add 0.7 volume of 
isopropanol (typically 500 µl). Gently invert several times to mix. Store at -20°C for 30 
min. Spin at 12,000 x g for 15 min at 4 °C. A white RNA pellet at the bottom of tube 
should be visible. Carefully discard supernatant and wash pellet once with 75% EtOH. 
Spin 8500 rpm at 4 °C for 5 min. Discard EtOH and air dry the tube for 5-10 min. Dilute 






2.2.7 DNA Extraction 
    Grow worm strains on NGM plates seeded with OP50 bacteria. Wash the worms from 
the plate with autoclaved water and pellet the worms by spinning at 3500 rpm for about 1 
minute. Aspirate off supernatant and repeat washing several times if needed. Flash freeze 
pellet in liquid nitrogen or -20°C freezer for 20 mins. Add five volumes of worm 
genomic DNA lysis buffer with proteinase K (0.1mg/mL) and incubate at 65 oC for 1-2 
hours. Deactivate proteinase K at 95°C for 20 minutes. Add RNase A to 0.1mg/mL and 
incubate at 37 oC 1 hour. Add 1 volume of tris-buffered phenol. Mix gently and spin at 
4,000 rpm for 5 minutes at room temperature. Transfer the aqueous phase to a new tube 
(Note: avoiding the phenol phase and interface). Extract once with 1 volume 
phenol/chloroform/isolamyl alcohol (25:24:1, v/v) and then with chloroform/isoamyl 
alcohol (24:1, v/v). Add 0.6 volume of -20°C isopropanol and thoroughly mix by 
inverting. The white DNA pellet should be visible after spinning 12000 rpm at 4°C for 5 
minutes. Wash once with 70 % EtOH and air dry at room temperature for 5-10 minute. 
Then resuspend genome DNA pellet in proper volume of ddH2O or TE. Take OD 
readings at 260nm (nucleic acids). 
 
2.2.8 Genome DNA shearing 
    The DNA was sheared using a biorupter (15secs on, 90 secs off, for 9 minutes). To 
construct six libraries (five candidate libraries and one control library) for sequencing, 1 






2.2.9 Polymerase chain reaction (PCR) 
2.2.9.1 Phusion High-Fidelity PCR  
    The 50 µl reactions of Phusion High-Fidelity PCR contains 10 µl 5X Phusion HF 
Reaction Buffer, 1 µl 10mM dNTP, 2.5 µl 10 µM Forward Primer, 2.5 µl 10 µM Reverse 
Primer, 10-1000 ng Template DNA, 1.5 µl DMSO, 0.5 µl Phusion DNA Polymerase and 
Nuclease-Free water. Cycling conditions start with initial denaturation at 98°C for 30 
secs and are followed by 30 cycles of polymerase chain reaction: 98 °C 10 secs, 60°C 30 
secs and 72°C with extension time of 1 kb per 15-30 secs. Phusion PCR is performed in 
either a DNA thermal cycler C1000 Touch (Bio-rad) or C1000 (Bio-rad). 
 
2.2.9.2 One Taq PCR 
    The 50 µl reactions of One Taq PCR contains 10 µl 5X one Taq Standard Reaction 
Buffer, 1 µl 10mM dNTPs, 1 µl 10 µM Forward Primer, 1 µl 10 µM Reverse Primer, 0.3 
µl One Taq DNA Polymerase, 10-1000ng Template DNA and Nuclease-Free water. 
Cycling conditions start with initial denaturation at 94°C for 30 secs and are followed by 
polymerase chain reaction for 30 cycles: 94 °C for 30 secs, 60°C for 45 secs and 68°C 
with extension time of 1 kb per min. PCR is performed in either a DNA thermal cycler 
C1000 Touch (Bio-rad) or C1000 (Bio-rad). 
 
2.2.9.3 Colony PCR  
Colony PCR was used to identify colonies that contains recombinant plasmids. The 








    RT-PCR was performed in two steps. Reverse Transcription (RT) was conducted by 
using ProtoScript II Reverse Transcriptase. First, denature sample RNA/Primers (10 µl 
volume contains 100ng-1 µg total RNA, 2 µl d(T)23VN (50 µM),1 µl 10mM dNTP and 
nuclease-free water) for 5 minutes at 65°C. Then add 4 µl 5X ProtoScript II Buffer, 2 µl 
0.1M DTT, 1 µl ProtoScript II RT (200 U/µl), 0.2 µl RNase Inhibitor (40 U/µl) and 2.8 
µl nuclease-free water. Incubate the reaction at 42°C for 1 h and inactivate the enzyme at 
65°C for 20 mins. Then use 1/10 of the products as template for Phusion PCR. 
 
2.2.10 PCR product purification 
    PCR purification is performed with QIAquick PCR Purification kit. Five volumes of 
Buffer PB are added to 1 volume of PCR products and mix. If the color of the mixture is 
orange, add 10 µl 3M, pH 5.0, sodium acetate to the solution and the mixture will turn 
yellow. Transfer the solution into QIAquick column and centrifuge for 1 min at 12000g. 
Wash column with 750 µl Buffer PE and centrifuge for 1 min at 12000g. Discard flow-
through and centrifuge 1 min to remove residual PE Buffer. Place QIAquick column in a 
clean 1.5 mL microcentrifuge tube and elute DNA with 35-50 µl Buffer EB. Let the 






2.2.11 DNA Digestion 
    Add 20 µl DNA (Plasmid vector or insert from PCR product), 5 µl 10X cutsmart 
buffer, 2 µl restriction enzyme and 23 µl sterile water and incubate at 37 °C for 3 hours. 
Stop digestion by heat inactivation at 65°C for 15 mins. The buffer added is according to 
NEBuffer Activity Chart for Restriction Enzyme. 
 
2.2.12 DNA ligation  
    Ligations can be done at room temperature (20-25°C). For cohesive ends, use 1 µl of 
T4 DNA ligase 2 µl 10X T4 DNA ligase buffer, 50ng vector DNA (0.020pmol), 
37.5ng(0.060pmol) insert DNA and nuclease-free water for 20 µl reaction. Incubate at 
room temperature for 1 hour or place it at 4°C overnight. 
 
2.2.13 Gel extraction 
    Gel extraction is performed with QIAquick Gel Extraction kit. Add 3 volumes of 
Buffer QG to 1 volume of gel and incubate at 50-60°C for 10 min until the gel slice is 
completely dissolved. If the color of the mixture is orange, add 10 µl 3M, PH 5.0, sodium 
acetate to the solution and the mixture will turn yellow. Add one volume of isopropanol 
to the solution and mix thoroughly. Transfer the mixture into QIAquick spin column and 
centrifuge for 1 min at 12000 x g. Wash column with 750 µl Buffer PE and centrifuge for 
1 min at 12000g. Discard flow-through and centrifuge 1 more min to remove residual PE 
Buffer. Place QIAquick column in a clean 1.5 mL microcentrifuge tube and elute DNA 
with 35-50 µl Buffer EB. Let the column stand for 1 min and then centrifuge at 12000g 





2.2.14 Gel electrophoresis of nucleic acids 
Negatively charged DNA can move on the agarose gel by electrophoresis. The agarose 
gel contains 1 x TBE buffer (90mM Tris Base, 2mM EDTA). 0.1 µl ethidium bromide 
and 1% agarose. 6 X Gel loading dye was mixed with DNA samples before loading into 
the slots.  The 1 kb DNA ladder was used as molecular size marker. 
 
2.2.15 Northern Blot 
    Use gel apparatus designated for RNA. Wipe apparatus with “RNase Away”. Make 1% 
Agarose gel (100ml) which contains 73 ml sterile water,1 g agarose, 10 ml 10X MOPS, 
17 ml 37% Formaldehyde and Boil them in microwave for 3 min.  Prepare 8 µg of RNA 
for each sample. Add loading dye and formamide to make the final volume to 20 µl. Run 
gel electrophoresis for 2 hours at 100V. Cut Amersham Hybond-N+ membrane (GE 
Healthcare Life Science) to the size of gel. Soak Hybond-N+ membrane in 5 X SSC. 
Place gel on the membrane and use vacuum blotting. The RNA samples on the gel were 
then transferred to Hybond-N+ with vacuum pump for 2.5h. Then crosslink RNA to blot 
with UV using Stratalinker on energy mode at 1800mJ/cm2. Prehybridize blot at 55°C 
for 1 hour in Hybridization Solution (4% blocking reagent, 0.5M sodium chloride). Use 
roller bottle in hybridization oven. Prepare cDNA probe following protocol (Amersham 
Gene Images Alkphos Direct Labeling and Detection System). Add 15-20 µl of probes 
and hybridize blot at 55°C overnight. Preheat the primary wash buffer to 55°C. Discard 
hybridization buffer and add heated primary buffer (2 M Urea, 0.1% (w/v) SDS, 50 mM 




wash for 10 minutes at 55°C, with gentle agitation. Perform a further wash in primary 
wash buffer at 55°C for another 10 minutes. Place the blots in a clean container and add 
25 mL 1X secondary wash buffer (20x stock Tris base 121 g 1 M, NaCl 112 g 2 M, pH 
10.0. Dilute to 1X with 2 mL of 1 M MgCl2) with gentle agitation for 5 minutes at room 
temperature. Perform a further wash in fresh, secondary wash buffer at room temperature 
for 5 minutes. 
Drain the excess secondary wash buffer from the blots by using filter paper and place 
them (sample side up) on a clean plastic wrap. Pipette detection reagent 
(Chemiluminescent reagent CDP-Star) on to the blots (30–40 µl/cm2) and leave for 2–5 
minutes. Drain excess detection reagent by touching the corner of the blot with tissue. 
Wrap the blots in plastic wrap with blots DNA side up and place it in the film cassette. 
Place a sheet of autoradiography film (Hyperfilm™ ECL) on top of the blots in the dark 
room. Close the cassette and expose for 30 mins at room temperature and develop the 
film. If required, expose a second film for an appropriate length of time.  
 
2.2.16 DNA probe preparation for Northern blot analysis 
The DNA probe is made by Amersham Gene Images Alkphos Direct Labeling and 
Detection System with purified cDNA from RT-PCR. Add 100ng cDNA and add DNase-
free water up to 10 µl. Place 10 µl of the diluted DNA sample in a microcentrifuge tube 
and denature by heating at 100°C for 5 minutes. Immediately cool the DNA on ice for 5 
minutes and spin briefly. Add 10 µl of reaction buffer, 2 µl labelling reagent, 10 µl of the 




for 30 minutes at 37°C. The probe can be used right way or kept on ice for up to 2 hours. 
To preserve for a long time, probes can be stored in 50% (v/v) Glycerol at -20°C. 
 
2.2.17 Genetic cross 
    C. elegans are grown up and maintained on NGM plates seeded with E. coli OP50. 
Males from one strain can be obtained using him-14 RNAi or incubate worms at 37°C for 
45 minutes. 
    Put 2-3 L4-stage hermaphrodite worms of one strain on a petri with 5-8 L4 males of 
the second strain. Incubate at 24°C (ideal for germline expression) or 20°C (in the case of 
adult expression) for 24 hours. Kill all the P0s (hermaphrodites as well as males). If you 
can find many males in the F1 progenies, your crossing is successful. After 24 hours, 
transfer 4 individual F1 hermaphrodites from crossing plate to single petri dish and let 
them grow up to lay eggs. Pick a total of 16 individual F2 worms from petri dish and let 
grow up to adulthood. Check the phenotype or genotype in F3 progenies usually by PCR 
or florescence visualization. We always introduce FR1gfp replicon into the RNAi-




    A significant advance in nematode transgenics was the discovery of microparticle 
bombardment that can induce integrative transformation in C. elegans [105]. With this 




ligate to chromosomes during DNA repair. Outcross of integrated strain with wild type 
several times is required at following step. 
 
2.2.19 single molecule Fluorescent In-Situ Hybridization (smFISH) 
Fixation: 
smFISH was performed by using fluorophore-conjugated probes, Hybridization Buffer, 
Wash Buffer A, B from BioSearch Technologies, which are specifically designed for 
RNA FISH. Larvae were grown in a plate seeded with regular OP50 bacteria or OP50 
with Orsay virus. All the worms are washed off by Nuclease-free water. Spin down 
worms and incubate them in 1 ml fixation buffer (10% (vol./vol.) 37% Formaldehyde 
solution, 10% (vol./vol.) 1 X Phosphate Buffered Saline (PBS)) at room temperature for 
45 min. Then spin down and wash twice with 1 ml 1 X PBS. To permeabilize, add 1 mL 
of 70% ethanol and store overnight at 4°C (Note: worms can be stored at 4 °C in 70% 
ethanol for at most one week).  
Hybridization: 
Centrifuge and aspirate off 70% ethanol. Add 1 ml of Wash Buffer A, and incubate at 
room temperature for 2-5 minutes. Aspirate Wash Buffer A and dispense 100 µl of the 
Hybridization Buffer containing proper amount (1-5 µl) of probes into the tube. Incubate 
samples in the dark at 37 °C for at least 4 hours. Then add 1 ml of Wash Buffer A to the 
tube and incubate in the dark at 37 °C for 30 minutes. Aspirate Wash Buffer A and add 1 
ml Wash Buffer A containing 5 ng/mL DAPI to counterstain the nuclei and incubate in 
the dark at 37 °C for 30 minutes. Aspirate the supernatant and add 1 ml of Wash Buffer 




Mounting Medium (VECTORLABS) onto the hybridized worms. Place the worms onto a 
clean glass microscope slide and cover them with worm oil. The worms are ready to 
proceed to imaging. 
 
2.2.20 Sanger sequence preparation 
    The BigDye® Terminator v3.1 Cycle Sequencing Kit was applied to provide pre-
mixed reagents for Sanger sequencing reactions. Prepare 10 µl reaction mix (3.5 µl 2.5X 
BigDye reaction buff, 0.5 µl BigDye Terminator, 1 µl 3.2µM primer, 1-4 µl DNA 
Template, DNA nuclease free water to make the total volume as 10 µl) and perform 
thermal cycling conditions (Table 1). 
    Briefly centrifuge the reactions and add 30 µl 100% ethanol and 2.5 µl 125mM EDTA. 
Mix thoroughly by vortexing it. Wait for 15 min and then centrifuge at 12000 rpm for 20 
min at 4 ℃. Discard the supernatant and suspend sequencing products with 10 µl ABI 
Hi-Di Formamide. The samples are ready for Sanger sequencing. 
 







2.2.21 EMS mutagenesis 
Grow five 10 cm diameter Petri plates with worms. Wash all the worms with M9 and 
transfer them in a sterile, 15 ml centrifuge tube. Centrifuge at 2000 rpm for 5 minutes. 
Aspirate the liquid and use 2 ml of M9 to resuspend the worms. Dilute 20 µl EMS in a 
tube containing 2 ml M9. Then add this EMS diluted solution to the 2 ml of worm 
suspension to reach the final concentration of EMS at 47 mM. Place the tube horizontally 
in the fume hood and let the worms incubate for 3.5 hours. Aspirate the supernatant and 
discard it into a beaker containing 1N NaOH to inactivate the EMS. Add 5 ml M9 to the 
worms and invert the tube several times to wash the worms. Centrifuge at 2000 rpm for 5 
mins and aspirate the supernatant. Repeat the washing step at least 3 times. Suspend the 
worm pellet with M9 transfer them onto NGM plates seeded with OP50 bacteria. Let the 
mutagenized worms self-fertilize and screen the F2 generation progenies according to 
phenotypes. 
 
2.2.22 Library Construction 
    The preparation of library is performed by using TruSeq DNA PCR-Free Library 
Preparation Kit from Illumina. 
 
2.2.22.1 Genomic DNA shearing  
    Prepare 10 µg input genome DNA for each library. Use Diagenode bioruptor NGS for 






    Quantify gDNA using electrophoresis and normalize gDNA with RSB to 55 µl. 
Centrifuge and transfer 52.5 µl DNA to Covaris tubes. Then centrifuge and transfer 50 µl 
supernatant to the CSP plate. Add 80 µl SPB, mix well and incubate at room temperature 
for 5 minutes. Put the tube on a magnetic stand and wait until the liquid is clear. Discard 
all supernatant and wash twice with 200 µl 80% EtOH. Remove EtOH carefully (Note: 
avoiding touching beads) and then air-dry beads on the magnetic stand for 5 minutes. 
Add 52.5 µl RSB to resuspend the beads. Remove the tube from the magnetic stand and 
vortex. Incubate at room temperature for 2 minutes and place it on a magnetic stand 
again. Wait until the liquid is clear. Transfer 50 µl supernatant to the IMP plate. 
 
2.2.22.3 Repair ends and library size selection 
    Add 10 µl CTE and 40 µl ERP2 or ERP3 and mix by pipetting. Place on the thermal 
cycler and run the ERP program by setting up 30°C for 30 minutes and Hold at 4°C.  
Dilute SPB with PCR grade water to 160 µl per 100 µl of end-repaired sample 
(Determine the volumes using Table 2). Vortex diluted SPB until well-dispersed.  
Table 2. The amount of SPB and PCR grade water needed in library size selection. 
Diluted SPB for a 350 
bp insert Size 




SPB # of samples X 
109.25ul 
1311ul  









    Add 160 µl diluted SPB and mix up. Incubate at room temperature for 5 minutes. Put 
the tube on a magnetic stand and wait until the liquid is clear. Suck up 250 µl supernatant 
and transfer it to the CEP plate. Add 30 µl SPB and mix well. Incubate it at room 
temperature for 5 minutes. Place the tube on a magnetic stand and wait until the liquid is 
clear. Discard all supernatant and wash twice with 200 µl 80% EtOH. Remove all the 
EtOH and air-dry on the magnetic stand for 5 minutes. Add 17.5 µl RSB after removing 
the tube from the magnetic stand and mix by vortex. Incubate at room temperature for 
another 2 minutes. Place on a magnetic stand and wait until the liquid is clear. At last, 
transfer 15 µl supernatant to the ALP plate. 
 
2.2.22.4 Adenylate 3’ Ends of DNA fragments 
    Add 2.5 µl RSB, 12.5 µl ATL or ATL2, and then vortex it. Use thermal cycler and run 
the ATAIL70 program by choosing the preheat lid option and set it to 100°C. Reaction is 
proceeded at 37°C for 30 minutes, 70°C for 5 minutes and 4°C for holding. 
2.2.22.5 Ligate Adapters to DNA fragments 
Add 2.5 µl RSB, 2.5 µl LIG2, 2.5 µl DNA adapters and mix thoroughly. Centrifuge at 
280 × g and add 5 µl STL. 
 
2.2.22.6 Clean Up Ligated Fragments 
Add SPB 42.5 µl and incubate at room temperature for 5 minutes. Put the tube on a 
magnetic stand and wait until the liquid is clear. Remove all the supernatant and wash 2 
times with 200 µl 80% EtOH. Remove residual EtOH and air-dry the beads on the 




stand. Resuspend the beads by vortex and Incubate at room temperature for 2 minutes. 
Centrifuge at 280 × g for 1 minute and place the tube on a magnetic stand again. Wait 
until the liquid is clear, then transfer 50 µl supernatant to the CAP plate. Repeat the steps 
above by adding 50 µl SPB and using 22.5 µl of RSB in the later step.  At last, transfer 
20 µl supernatant to the TSP1 plate. (See Table 3 for all acronym definition) 
Table 3. Acronym Definition 
ALP Adapter Ligation Plate 
ATL A-Tailing Mix 
CAP Clean Up ALP Plate 
CEP Clean Up End Repair Plate 
CSP Clean Up Sheared DNA Plate 
CTA A-Tailing Control 
CTE End Repair Control 
CTL Ligation Control 
DAP DNA Adapter Plate 
DCT Diluted Cluster Template Plate 
DNA Customer Sample DNA Plate 
ERP End Repair Mix 
IMP Insert Modification Plate 
LIG Ligation Mix 
PDP Pooled Dilution Plate 
RSB Resuspension Buffer 
SPB Sample Purification Beads 
STL Stop Ligation Buffer 





2.2.23 DNA library building and quality check 
    DNA libraries were constructed by using PCR-free Truseq DNA kit (Illumina). 
Indexed sequences of each candidate mutant are shown below (table 4). Gel analysis and 
Bioanalyzer are utilized to check the quality and quantity of libraries by observing the 









 Table 4. Information of Indexed adaptor for each candidate library 











CHAPTER 3: DEVELOPMENT OF A REPORTER WORM 
STRAIN FOR BIASED GENETIC SCREEN 
 
Introduction 
RNA interference is an essential immune response to RNA virus across species. In the 
recent study, RNAi as an antiviral immune mechanism was also found in mammals [7-9]. 
In the invertebrate Caenorhabditis elegans, the antiviral RNAi process is initiated by a 
single dicer, which is in the RNase III family that specifically binds and cleaves dsRNA. 
The efficient recognition process requires RDE-4 (RNA defective 4), a dsRNA binding 
protein and DRH-1, which encodes helicase and C-terminal domains homologous to the 
mammalian RIG-I-like helicase family of cytosolic immune receptors. After dsRNAs are 
processed into siRNAs, the siRNAs are then loaded into RDE-1 (RNA defective 1), an 
Argonaut protein which is an important component in RISC and guides RISC to target 
mRNA by complementary mechanism for subsequent mRNA destruction. Antiviral 
RNAi can also be amplified in nematodes. RdRP and RSD-2 contribute to the biogenesis 
and functionality of secondary siRNA. However, the underlying molecular mechanisms 
are not well understood. In the current study, I developed a biased genetic screen strategy 
to identify novel genes involved in RDVI, which may help us gain insight into the 
molecular mechanisms. Four critical genes involved in C. elegans RDVI (drh-1, rde-1, 
rde-4, rrf-1), an artificial virus FR1gfp and a transgene reporter (Pmyo2::mCherry) were 
delivered together into rde-1; rde-4 double mutant through gonad microinjection. The 
high viral susceptibility was reduced by ectopic expression of the rde-1 and rde-4. I then 
examined FR1gfp expression by using feeding RNAi-based assays and confirmed its 




RDVI response, suggesting the existence of drh-1 and rsd-2 transgenes in the transgenic 
array. I also studied antiviral response of our transgene array in drh-3 and rrf-1 (RNA-
dependent RNA polymerase) background, in which the replication of viruses was readily 
detected, suggesting that overexpression of drh-1, rde-1, rde-4 and rsd-2 does not 
compensate the loss of antiviral RNAi in rrf-1 or drh-3 mutants. Thus, when wild-type 
N2 worms that contain the developed transgene array are used for large scale genetic 
screen, any loss of function alleles associated with drh-1, rde-1, rde-4 and rsd-2 will be 
automatically rejected, which will significantly speed up our gene discovery process. 
There are two types of genetic screen strategies in the worm system: forward genetics 
and reverse genetics. Forward genetic screen is the most common genetic screen for 
identifying recessive mutations. Typically, P0 hermaphrodites are treated with mutagen at 
late L4 or early adult stages. F1 progenies, heterozygotes are allowed for self-fertilization 
and F2 animals are screened based on the phenotype expected. The most widely used 
mutagen for C. elegans is EMS as well as trimethylpsoralen with ultraviolet light 
(UV/TMP) [106]. Reverse genetic screen begins with the generation of worm mutants by 
targeting and downregulating each of the worms’ genes. Then, the candidate gene can be 
identified by screening for phenotypes that are generated as a result of gene silencing. In 
1998, ingesting of dsRNA from bacterial food was found to trigger potent silencing of 
homologous gene [36, 37]. This finding makes it possible for rapid gene discovery 
through reverse genetic screen in C. elegans. However, both strategies for genetic screen 
have their drawbacks. Forward genetic screen requires a large workload and amount of 
lab resources. This is mainly because although it is relatively easy to isolate genetic 




conventional map-based cloning strategy is labor intensive and cost ineffective process. 
In a reverse genetic screen, although it is easy to find out which gene is involved once the 
desired phenotype is identified, sometimes it is difficult, if not impossible, to achieve 
complete silencing of the target gene through feeding RNAi. Previously it has been 
shown that feeding RNAi does not work well when the target gene itself is a key 
component of RNAi. Therefore, I have chosen to use forward genetic screen strategy for 
gene discovery in our study.  The efficiency of the screen is dramatically improved by (1) 
using virus as reporter so that the genes specifically contributing to antiviral defense will 
be targeted; (2) introducing extra copies of four known antiviral RNAi genes can 




















3.1 FR1gfp: a viral reporter for loss of antiviral RNAi in C. elegans 
    In our study, I utilized a viral replicon transgene called FR1gfp as the reporter for loss 
of antiviral RNAi in C. elegans.  
    FR1gfp is engineered using flock house virus RNA1 as backbone [107]. FHV is a 
positive-strand RNA virus in the family Nodaviridae. FHV contains two genomic 
segments called RNA1 and RNA2. RNA1 encodes the viral RdRP (Fig 12B) whereas 
RNA2 encodes precursor protein of the coating protein (Pre-CP) (Fig 12C). RNA1 can 
 
Fig 12.  Schematic representation of FR1gfp transgene and genome structure of Flock House 
Virus. (A) FR1gfp transgene is generated based on Flock House Virus RNA1 by replacing B2 
with GFP. A heat-shock promoter (HSP) is at 5‘ end and a self-splicing ribozyme sequence is 
at the 3’ end. After heat induction, the subgenomic RNAs containing GFP sequence, are 
produced. (B) Expression of wild type FHV RNA1 (FR1) produces FHV RdRP and 
expression of FHV RNA3 (FR3) produces RNAi suppressor B2 protein of FHV. (C) 





perform self-replication in the absence of RNA2. The 3' end of RNA1 encodes a 
subgenomic RNA called RNA3, which is transcribed during RNA1 replication (Fig 12B). 
RNA3 is required to initiate FHV infection under normal condition since it encodes the 
RNAi suppressor protein B2 (Fig 12B) [108].  
    It is important to note that FR1gfp is defective in RNAi suppression because B2, the 
RNAi suppressor, is replaced by GFP. Therefore, B2 function is totally disrupted, but 
replication and expression of viral RNA1 is not influenced when antiviral RNAi is 
defective. In addition, a self-cleaving ribozyme sequence is fused to the 3’ end of FR1gfp 
so that the poly-A tail, which can inhibit viral replication, will be removed by the 
ribozyme (Fig 12A).  
Under normal condition, FR1gfp cannot replicate due to the loss of B2 function. 
However, if antiviral RNAi is suppressed as a result of B2 co-expression or genetic 
disruption of RNAi activity, FR1gfp and gfp expression will be restored. In this way, 
replication of FR1gfp can be easily visualized by observing GFP in the worm body. 
Therefore, FR1gfp can be used as viral reporter to look for genes required for antiviral 
defense.  
 
3.2 Development of the plasmid constructs that express wild-type rde-1 and rde-4 in C. 
elegans 
I developed two transgenes, Psur-5::rde-1::UTR and  Psur-5::rde-4::UTR, that will 
express wild-type rde-1 and rde-4 in C. elegans. The Psur-5 promoter can initiate the 
transcription in almost all the cells of C. elegans, including the vulva precursor cells 




important role in transcription termination and serves as target for microRNAs 
(miRNAs) to bind, thus influencing the expression of genes. Wild-type rde-1 and rde-4 
cDNA are synthesized from corresponding mRNAs extracted from wild type N2 worms.  
 
3.3 Generation of a reporter transgene array for biased genetic screen 
      The reporter transgene array to be generated is expected to harbor six transgenes. 
Four constructs (Psur-5::rde-1::UTR, Psur-5::rde-4::UTR, Psur-5::drh-1::UTR,  Psur-
5::rsd-2::UTR)  will be delivered to express four  known genes involved in antiviral 
RNAi. These four constructs will direct the expression of rde-1, rde-4, drh-1 and rsd-2 
respectively. The other two transgenes are Pmyo2::mCherry reporter and HIP::FR1gfp 
transgene (Fig 13). The Pmyo-2::mCherry-derived transgene is expected to direct 
 
Fig 13. The figure shows the structure of transgene array including Psur-5::rde1::UTR, Psur-
5::rde4::UTR, Psur-5::drh-1::UTR, Psur-5::rsd-2::UTR, HIP::RdRP::GFP, 
Pmyo2::mCherry::UTR. Psur-5, the promoter for the endogenous gene sur-5; rde-1, the 
coding sequence of wild-type rde-1; rde-4, the coding sequence of wild-type rde-4; drh-1, the 
coding sequence of wild-type drh-1; rsd-2, the coding sequence of wild-type rsd-2; UTR, the 






mCherry expression in the head of transgenic worms and, thus, will serve as selection 
marker for the transgene array to be created. The HIP:FR1gfp-derived transgene will 
serve as reporter of loss of antiviral RNAi in this study.  
 
3.3.1 Generation of a reporter extrachromosomal array in rde-1; rde-4 double mutants.  
    In C. elegans, gonad injection of target gene construct often leads to the formation of 
extrachromosomal arrays that are made of multiple copies of the target constructs. This 
unique feature has made it possible to co-deliver many genes into C. elegans genome in a  
single transformation process. Based on this observation, I decided to develop a unique 
reporter worm strain that will allow for rapid identification of novel RDVI genes in C. 
elegans. Such a unique reporter worm will contain a transgene array that harbors a viral 
 
Fig 14. RDVI was restored in rde-1;rde-4 double mutants containing the extrachromosomal 
array generated through gonad injection. Co-injection of 6 plasmid constructs shown in Figure 
13 restored antiviral RNAi in rde-1;rde-4 double mutants that contain an FR1gfp transgene. 
There are four worms in the picture, two worms on the left contain extrachromosomal array 
(red fluorescence in the head) and two on the right without it (no red fluorescence in the 
head). Visualization of GFP was performed 24 hours after heat induction. The image was 





reporter transgene and four more transgenes corresponding to drh-1, rde-1, rde-4 and rsd-
2. Genetic screen utilizing a reporter worm strain that contains extra copies of drh-1, rde-
1, rde-4 and rsd-2 will not pick up any alleles associated with these four genes. As a 
result, the screen efficiency will be significantly improved. To develop such a reporter 
worm strain, I mixed 6 plasmid constructs, corresponding to Pmyo-2::mCherry::UTR, 
HIP::FR1gfp, Psur-5::drh-1::UTR, Psur-5::rde-1::UTR, Psur-5::rde-4::UTR, and Psur-
5::rsd-2::UTR respectively (Figure 13), and injected them into rde-1;rde-4 double 
mutants that already contain an HIP::FR1gfp-derived transgene. My injection produced 5 
independent strains that carry extrachromosomal arrays visualized as red fluorescence in 
worm head. To find out whether functional Psur-5::rde1::UTR, Psur-5::rde-4::UTR 
transgenes were successfully incorporated into the extrachromosomal arrays, I checked 
FR1gfp replication, manifested by GFP expression, in the worms that contain the 
extrachromosomal arrays. In all the 5 transgenic strains, as shown in Figure 14, bright 
green fluorescence was observed in progeny worms that are free of the extrachromosomal 
arrays, whereas no green fluorescence was detected in progenies that carry the 
extrachromosomal arrays (compare worms showing no red fluorescence in head and 
worms with red fluorescence in head).  
       To reconfirm this result, I generated a chromosomal integrant, named 48, for one of 
the 5 transgenic strains and checked the accumulation of FR1gfp-derived viral RNAs 
using northern blots. As shown in Figure 15A, FR1gfp derived genomic (RNA1) and 




double mutants but not in 48 worms. These findings together suggest that the 
chromosomal integrant 48 contains functional rde-1 and rde-4 transgenes.  
    Orsay virus is a novel RNA virus distantly related to nodaviruses. This virus was 
isolated from the C. elegans strain JU1580 based on the observation that JU1580 has 
abnormal morphological phenotypes in intestinal tissue [110]. When Fluorescent In-situ 
Hybridization (FISH) was used to detect Orsay virus RNA using sequence-specific 
probes, it was clear that Orsay virus only replicates in the intestinal cells [110]. In 
previous studies, Orsay virus was shown to accumulate to a much higher level in RNAi 
mutants, compared to that in wild type N2 worms, suggesting that Orsay virus invokes 
and is under the control of RDVI response in C. elegans. These findings together 
 
Fig 15. RDVI is restored in the chromosome integrant 48. (A) Accumulation of FR1gfp 
transcripts in single and double mutants corresponding to rde-1 and rde-4 as indicated. * 
indicates worms that carry the 48 transgene array. The FR1gfp transcripts were detected by 
northern blotting, for which the probe was prepared using GFP coding sequence; RNA1, 
FR1gfp genomic RNA; RNA3, FR1gfp subgenomic RNA. Methylene blue stained ribosomal 
RNA (rRNA) serves as equal loading control. (B) Northern blot detection of Orsay virus 
RNA1, OvRNA1, in single and double mutants corresponding to rde-1 and rde-4 as indicated. 
* indicates worms that carrying the 48 transgene array. Orsay virus RNA1 cDNA was used to 





suggested that Orsay virus is a good model virus to study essential genes required for 
antiviral immunity in C. elegans [110]. 
    The genome structure of Orsay virus is very similar to that of FHV. Both viruses 
contain two genomic segments with RNA1 encoding RNA-dependent RNA polymerase 
and RNA2 encoding the precursor protein of viral coating protein (Fig 16). However, 
currently there is no experimental evidence to show that Orsay viruses generate 
subgenomic transcripts from the RNA1 like FHV RNA1 does. Thus, Orsay virus RNA1 
may not encode suppressor proteins. For detection of Orsay virus infection, I prepared 
cDNA probes that are complementary to the segment of Orsay virus RNA1.  
As shown in our northern blot analysis, the accumulation of Orsay virus RNA1 in the 
rde-1;rde-4 double mutants containing the transgene array is much lower than that in 
single and double mutants that do not contain the transgene array (Fig 15B). The 
 
 
Figure 16. Schematic of genomic organization of Orsay virus. The RNA1 segment (2,680 
nucleotides) encoded a predicted ORF (open reading frame) of Orsay virus RdRP, and the 
RNA2 segment was predicted to encode a capsid protein at its 5’ end. A second ORF 





Northern blot results of Orsay virus replication strongly confirmed that in 48 worms both 
rde-1 and rde-4 transgenes are functional. 
 
3.3.2 Characterization of the FR1gfp transgene in the reporter transgene array 
       To develop a reporter worm strain for the identification of novel RDVI genes, I 
introduced the reporter transgene array generated in 48 worm which is marked by the  
Pmyo-2::mCherry transgene into wild type N2 worms and obtained a new strain named 
48/N2. 48/N2 worms are free of any developmental defects and, thus, would serve us 
well as a reporter worm strain for the identification of RDVI genes if the viral reporter 
FR1gfp in the transgene array is functional. To find out whether the viral reporter FR1gfp 
 
Fig 17. The Viral reporter FR1gfp is functional in 48/N2. (A) Visualization of green 
fluorescence in 48/N2 worms subjected to feeding RNAi targeting rde-1 and rde-4. 
Photographs were taken 24 hours after induction of the replicon replication. See content in 
2.1.2 for experimental details. There are four worms sticking together in the left picture, three 
worms in the middle picture and five worms in the right picture (B) Accumulation of Orsay 
virus RNA1 in rde-1 and rde-4 mutants and wild type N2 worms that carry the 48 transgene 
array. * indicates worms that were fed with E. coli food expressing rde-1 dsRNA. ** 





in 48/N2 is indeed functional, I checked GFP expression when the expression of rde-1 
and rde-4 is downregulated by feeding the 48/N2 worms with food expressing rde-1 or 
rde-4 dsRNA. The feeding RNAi would silence both endogenous genes and transgenes 
corresponding to rde-1 or rde-4 thereby to rescue the replication of FR1gfp, leading to 
the production GFP fluorescence. Indeed, as shown in Fig 17A, in response to rde-1 or 
rde-4 dsRNA feeding, FR1gfp is able to replicate and produce green florescence after 
heat induction. 
    To find out whether the expression of rde-1 and rde-4 can be suppressed to enable the 
infection by natural viral pathogens, such as Orsay virus, I challenged the 48/N2 worms 
with Orsay virus when rde-1 or rde-4 were silenced by feeding RNAi. As shown in 
Figure 17B, the accumulation of Orsay virus was significantly increased when 48/N2 
worms were fed on E. coli food expressing either rde-1 or rde-4 dsRNA. These results 
thus confirmed that RDVI in 48/N2 worms can be subdued by dsRNA feeding to allow 
for the infection by natural viral pathogens.  
    These results together suggest that both FR1gfp reporter transgene and the transgenes 




3.3.3 Characterization of the drh-1 and rsd-2 transgene in the reporter transgene array 
     To find out whether the drh-1 and rsd-2 transgenes in the 48/N2 worms are functional 
for antiviral defense, I delivered the corresponding transgene array into drh-1 and rsd-2 
mutants by genetic cross and tested both FR1gfp and Orsay virus replication in the new 
strains 48/drh-1 and 48/rsd-2. I reasoned that if the drh-1 and rsd-2 transgenes in the 
transgene array are functional, they should be able to rescue the function of endogenous 
drh-1 and rsd-2 and, as a result, the replication of both viruses will be suppressed in 
48/drh-1 and 48/rsd-2 worms. Indeed, as shown in Figure 18A and Figure 18B, the 
replication of FR1gfp and Orsay viruses was suppressed in drh-1 and rsd-2 mutants 
containing the transgene array. Apparently, the restoration of RDVI in 48/drh-1 and 
48/rsd-2 worms can only be ascribed to the function of drh-1 and rsd-2 transgenes 
respectively as the replication of FR1gfp and Orsay virus was restored when the 
expression of drh-1 and rsd-2 transgenes were silenced by dsRNA feeding.  
 
Fig 18. Both drh-1 and rsd-2 transgenes have been successfully integrated into the transgene 
array 48. (A) Northern blot detection of FR1gfp replication in transgenic worm strains, as 
indicated, that contain the 48 transgene array after heat induction. See content of 2.1.2 for 
experimental details. (B) Accumulation of Orsay virus RNA1 in drh-1 and rsd-2 mutants and 
wild type N2 worms that carry the 48 transgene array. In both figure 18A and B, * indicates 
worms that were fed with E. coli food expressing drh-1 dsRNA. ** indicates worms that were 




3.4 Sensitivity test of the reporter worm strain 
  Recent studies have shown that DRH-3 is required for germline development and 
RNAi by participating in the biogenesis of endo-22G RNAs [46, 111, 112]. Consistent 
with these observations, we have recently demonstrated that drh-3 mutant is susceptible 
to the infection by both Orsay virus and FHV [3], suggesting a role of drh-3 in RDVI.  
 The RNA-dependent RNA polymerase RRF-1 is required for the production of 
secondary siRNAs and has been shown to play a role in RDVI [30, 38, 40, 43, 91]. 
However, unlike that in drh-1 or rde-1 mutants where the viral replication can be fully 
restored, viral replication in rrf-1 mutants can only be partly restored [7].  
To rule out the possibility that overexpression of four RNAi worm genes 
compensates the function loss for some other antiviral RNAi genes, making my reporter 
worm strain less sensitive in picking up some loss of function alleles, I decided to check 
whether virus replication is suppressed in rrf-1 and drh-3 mutants containing the reporter 
 
Fig 19. Virus replication in 48/drh-3 and 48/OK589 in dsRNA feeding-based assays. (A) 
Northern analysis of Orsay virus accumulation in 48/drh-3. N2, drh-3 and 48/N2 were set as 
control. (B) Northern analysis of Orsay virus accumulation in 48/OK589 and 48/drh-3. (C) 
Northern analysis of FR1gfp accumulation in 48/OK589. 48/N2 and 48/drh-3 were used as 




transgene array. To this end, I introduced the reporter transgene array into drh-3 and rrf-1 
worms and checked viral replication in the resulting worm strains. As shown in Fig 19A 
and B, both 48/drh-3 and 48/rrf-1 are highly susceptible to Orsay virus infection.  
 Consistently, I observed green fluorescence in both 48/drh-3 and 48/rrf-1 worms 
although a higher percentage of green fluorescent worms was observed in 48/drh-3 strain 
compared to that in 48/rrf-1 strain. Our Northern blot analysis confirmed that the FR1gfp 
RNAs indeed accumulated to a higher level in 48/drh-3 worms than that in 48/rrf-1 
worms and both worms strain showed higher viral replication than the 48/N2 worms (Fig 
19C). These results together suggest that the 48/N2 worms will be sensitive enough to 
pick any genetic alleles that compromise worm RDVI. 
 
Discussion 
To develop a reporter worm strain that will allow for the identification of novel 
RDVI genes without hitting previous identified ones, I generated a transgene array that is 
expected to contain an FR1gfp viral reporter and transgenes corresponding to 4 known 
RDVI genes, drh-1, rde-1, rde-4 and rsd-2. The transgene array was generated in rde-1 
and rde-4 double mutants through gonad microinjection. The restoration of RDVI in the 
double mutants suggests that both rde-1 and rde-4 transgenes in the transgene array are 
functional (Figure 14, 15). To find out whether the viral reporter transgene FR1gfp was 
successfully delivered into this transgene array, I checked GFP expression in worms 
containing this transgene array. I found that when the expression of rde-1 or rde-4 was 
suppressed by feeding RNAi, green fluorescence can be observed in worms carrying this 
transgene array, confirming the viral reporter FR1gfp was indeed successfully delivered 




and rsd-2 in respective loss of function mutants (Figure 18A, B), suggesting that all these 
RDVI transgenes in the transgene array are functional. Importantly, RDVI remains 
defective in drh-3 and rrf-1 mutants containing the transgene array (Figure 19), 
suggesting that overexpression of four known RDVI genes does not compensate for the 
function loss of other RDVI genes. The results indicate that wild-type N2 worms carrying 
this transgene array will serve us well as a reporter for the identification of novel RDVI 
genes through genetic screen. 
      In this study, I chose FR1gfp, which is modified from FHV RNA1, as the reporter for 
large-scale genetic screen [107]. The GFP coding sequence was used to replace part of 
RNA3 sequence so that B2 function is destroyed but the function of RdRP is not affected. 
Therefore, FR1gfp is able to replicate in the strains deficient in antiviral defense, but not 
in the strain where antiviral RNAi machinery is still functional. The replication of 
FR1gfp can be easily visualized by observing GFP in the body muscle (Fig 20), making it 
practical to screen genes specific for antiviral defense. 
 
Fig 20. Visualization of GFP in two worm strains with FR1gfp transgene. The worm at top is 






      Based on the previous study, I believe that Orsay virus could serve as an alternative 
viral reporter for loss of antiviral RNAi. In theory, it should be possible to create Orsay 
virus replicon harboring GFP sequence for visualization of viral replication. For instance, 
GFP sequence could be fused to Orsay virus RNA1 to generate fluorescent version of 
Orsay RNA1 transgene. After introducing the transgene into RNAi defective worm 
strain, Orsay virus replication can be visualized. This transgene is also ideal as a viral 
reporter for large-scale genetic screen for host antiviral genes. However, it seems there 
are some limitations on the size of insertions that can be tolerated in Orsay virus genome 
[113].  Currently it remains to be a challenge to generate an Orsay viral based reporter. 
Using FR1gfp as a reporter for genetic screens has three major advantages. First, this 
reporter allows for identification of genes specifically involved in antiviral defense. 
Second, GFP as a visual mark of viral accumulation is easy to detect. Third, FHV 
replicates in insects, plants, yeast and animals. Thus, FR1gfp can be used as reporter for 
loss of antiviral RNAi in genetic screens in other systems. Since many key antiviral 
RNAi genes are conserved across kingdoms, study on the conserved genes may have 
direct input to antiviral RNAi study in other systems. There are disadvantages associated 
with the FHV reporter as well. For example, the initiation of FR1gfp through the 
transgene strategy often results in very high level viral replication. As such, the function 
of host antiviral RNAi machinery may become saturated, leading to false positive during 
genetic screens. This is why repetitive reconfirmation is always required to get rid of the 
false-positives. Sometimes, the sudden increase of FR1gfp transcripts can be lethal. This 
is mainly because the basic cellular functions are compromised as a result of irregular 




    Although it is possible to generate a large transgene array in C. elegans using the 
gonad microinjection technique, the expression of different transgenes in the transgene 
array can vary dramatically. This is mainly because different transgenes may have 
different copy numbers in the transgene array. Sometimes, some transgenes may simply 
become silenced due to the triggering of gene silencing [114]. It was also observed that 
some transgenes have the so-called mosaic expression pattern: they are expressed 
normally in some tissues but become silenced in some other tissues. As a result, the 
transgene may be expressed in some of the progeny [115]. Therefore, it is important to 
pick up as many transgenic strains as possible for the selection of an ideal strain. It is 
important to note that for some worm genes it might be difficult to generate a functional 
transgene, especially those that are actively expressed in germline. Previously it has been 
shown that transgenes in germline cell are strongly silenced [116].  
  In spite of some potential problems or drawbacks in developing large transgene 
arrays, the reporter worm strain I have created seems working very well in this 
preliminary study. In theory, it is possible to include more known genes in our transgene 
array. I believe that the strategy can be adopted to dissect many other biological pathways 
in the worm systems. It is important to note that I did not introduce the dcr-1 gene into 
our transgene array. DCR-1 is essential to antiviral RNAi. However, it is also required for 
synthesis of small RNAs, such as miRNAs, that are essential for development. Therefore, 
irregular expression of dcr-1 may result in lethal embryos that will not hatch, making it 
impossible to isolate transgenic worms containing the dcr-1 transgene. It is also worth 
mentioning that I failed to develop a functional construct containing drh-3 gene. Both 




reasoned that this may be because drh-3 is an essential gene that is actively expressed in 
germline tissue. Initiation of drh-3 transcription requires a specific promoter that is 









































Genetic mutation is always the main force that drives creatures to evolve. In C. elegans, 
spontaneous point mutations arise at the rate of 2 × 10−8 per gene per generation [117]. 
Mutation is also an important tool for gene function study. In the laboratory mutagenesis 
techniques are widely used to produce various mutations in genes participating in the 
biological pathway of interest.    
Typically, there are three types of genome-wide mutagenesis: chemical, physical, and 
transposon insertional mutagenesis. Chemical mutagenesis offers the most convenient 
and easiest way to induce mutation. The most commonly used chemical mutagens in C. 
elegans are EMS and UV/TMP. EMS is an alkylating agent which adds an ethyl group to 
guanine and forms O6-ethylguanine [118]. The modified guanine can pair with thymine 
instead of cytosine during DNA replication [119]. Therefore, the original G/C base pair 
becomes A/T base pair. Most of the time, this transition mutation leads to the generation 
of stop codons [120]. Consequently, the EMS-mediated mutations are normally loss-of 
function or null allele.      
    TMP is a light-sensitive crosslinker of DNA, whose mutagenicity is activated by UV 
light [121]. Reportedly, UV/TMP generates small deletions with the size of approximate 





    Physical mutagens include various types of radiations. For example, X rays, gamma 
rays, UV light, etc. High-energy radiation can lead to large chromosomal deletions or 
chromosomal rearrangement at relatively high rate [122]. 
    Transposable element (TE or transposon) mutagenesis is achieved by transposon 
insertion via a transposase enzyme. Transposons are DNA sequences that can move from 
one location to another in the chromosome. Such a transposition process can result in 
various alterations, including insertion, excisions, translocation and duplication [123]. 
In C. elegans, there are six families of endogenous transposons, Tc1-Tc5 and Tc7 [124-
129]. These transposons can be activated in Mutator background. For example, Tc1, the 
most enriched transposon, can be effectively activated in mut-6 (a Mutator gene) mutant 
[130]. Sometimes, an exogenous transposon Mos1-based method is preferred. Mos1, 
which originates from Drosophila, is more likely to be inserted in introns presumably 
because the areas tend to be T/A rich [131]. 
My biased genetic screen is based on forward genetic screen that uses EMS as 
mutagen. I choose to use EMS as mutagen for three reasons: First, EMS mutagenesis is 
very easy to administer. Second, EMS has the best efficiency of mutagenesis, compared 
to physical method, transposon insertional methods and even the most popular UV/TMP 
method. In other words, fewer animals are needed to be scored to identify a phenotype of 
interest while using EMS mutagenesis in comparison with other methods [132]. Third, 
transposon-mediated and radiation-based methods produce more complicated mutations 
such as small indels (insertions and deletions) or chromosomal rearrangement [122, 133]. 




After mutagenizing my reporter worms with EMS, altogether 25 candidate alleles were 
identified and were assigned to 13 candidate genes through genetic complementation 
tests. Two of the alleles, 1025A and B09, turned out to have derived from rrf-1 and 
1031B was confirmed to be a loss of function allele of rde-3. All of them were identified 
through genetic complementation tests and validated by Sanger sequencing and function 
rescue test. When I conducted tests that aim to determine whether these genes are 
involved in both classical RNAi and antiviral RNAi, it was surprising to see three of the 
asd (antiviral silencing deficient) genes are required for both classical RNAi and antiviral 
RNAi. Other genes are very likely only required for antiviral RNAi or an RNAi-
independent antiviral mechanism in C. elegans. More strikingly, some of these antiviral-
dedicated genes are critical for FHV antiviral response but do not confer resistance to 
Orsay virus. After introducing Orsay RdRP as transgene into these mutants, I used 
smFISH technique to detect the location of Orsay virus replication. Different patterns of 
Orsay virus replication were detected for transgene-delivered Orsay virus, compared to 
that during natural Orsay virus infection. Thus, these genes may function in a tissue-










4.1 EMS mutagenesis 
      My biased genetic screen is based on forward genetics. To identify antiviral-deficient 
strains, the reporter strain 48/N2 P0 hermaphrodites were mutagenized by EMS at the late 
L4 or early adult stages. F1 progeny, heterozygous for many induced mutations, were 
then allowed to self-fertilize. I triggered FR1gfp replication by heat inducing F2 
progenies at 33C for 3 hours (Fig 21).  The candidate strains that produced green 
fluorescence were further confirmed by heat inducing the F3 progenies. The biased 




Fig 21. Schematic of strategy for genetic screen triggered by EMS mutagenesis. After treating 
with EMS mutagen, F1 heterozygotes contain mutations. In the F2 progenies, homozygotes 




4.2 Characterization of the candidate mutants through genetic complementation  
Table 5. Thirteen candidate genes assigned by genetic complementation and their 
physiological characteristics. 







Asd-1 D02 ++++ + Reduced brood size 
1027e +++ + Reduced brood size 
1026 (D03) +++ + Reduced brood size 
1103a ++++ + Reduced brood size 
Asd-2 1026b(B01) ++++ - - 
1028g ++++ - - 
1029e ++++ - - 
Asd-3 1029c ++++ - - 
1031e ++++ - - 
1102b +++ - - 
Asd-4 1025b +++ - - 




Asd-5 1026a ++++ - Reduced brood size 
1031a ++++ - Reduced brood size 
1031f ++++ - Reduced brood size 
Asd-6 (rde-3) 1031b ++++ - - 
Asd-7 1028j ++++ - - 
Asd-8 1030d +++ - - 
Asd-9 1026d(B05) +++ - - 
Asd-10 1105a +++ - Reduced brood size 
Asd-11 1030c +++ - High frequency of 
males 
rrf-1 1025a +++ - - 
B09 +++ - - 





    In genetics, complementation occurs when two genetic alleles derived from different 
genes together produce wild type phenotype. Non-complementation happens when the 
two genetic alleles are derived from the same gene. To find whether any of the isolated 
alleles are derived from the same gene all the candidate mutants were crossed to each 
other. In this complementation test, the phenotype is GFP expression in worm body 24 
hours after heat induction. In addition, I also crossed these candidate mutants with 
genetic mutants containing alleles corresponding to rrf-1, rde-2, rde-3, rde-10, rde-11, 
rde-12, and drh-3, hoping to identify alleles derived from these known RNAi related 
genes [40, 97, 134, 135].  
    25 candidate alleles were eventually assigned to 12 candidate genes through genetic 
complementation. I analyzed their physiological characteristics by comparing GFP 
expression level 24 hours after heat induction at 37C, testing temperature sensitivity by 
allowing them to grow at 25C and checking brood size and male frequency (Table 5). 
These tests suggest that only asd-1 alleles are sensitive to temperature. They become 
sterile while growing at 25C. Moreover, asd-1, asd-5, asd-6 and asd-10 candidates have 
about 5-fold reduction of brood size compared to wild type, implying these genes may be 
essential for worm development. In addition, asd-11 allele has high frequency of males, 
indicating this gene is probably associated with X-chromosome segregation. 
    My genetic complementation tests suggested one candidate allele is derived from rde-3 
and two from rrf-1. Both rde-3 and rrf-1 are known RNAi genes with important function 
in antiviral defense. Thus, the isolation of rde-3 and rrf-1 derived alleles suggests a good 





4.3 Function characterization of the identified candidate genes 
        Next, I want to further characterize candidate genes by determining whether they 
contribute to both classical and antiviral RNAi. With a replicating virus as the trigger and 
target of RNAi, my genetic screen was expected to pick up genes with specific function 
in antiviral RNAi. I tested their function in RNAi triggered by dsRNA ingestion. I did not 
use the original mutants for this test, considering that some of the random mutations in 
the original mutants may have adverse effect on feeding RNAi. Thus, my test began with 
the introduction, through outcross, of the representative allele for each of the 12 asd 
genes into a transgenic worm strain termed 11 (Fig 22A). 11 worms contain two 
physically linked transgenes, a heat inducible FR1gfp transgene and a mCherry transgene 
(Fig. 22B).   
    The FR1gfp transgene produces green fluorescence upon Heat induction when antiviral 
RNAi is defective, whereas the mCherry transgene directs constitutive expression of 
 
Fig 22. (A) Strategy to deliver a transgene array termed as 11, which contains myo3mCherry 
reporter and a FR1gfp reporter through genetic cross and (B) the schematic structure of 
myo3mCherry transgene which has Pmyo-3 promoter at 5 prime and untranslated region at 3 





mCherry in body wall muscle and can serves as the target of feeding RNAi. Thus, after 
homozygous alleles corresponding to the identified genes were introduced into 11 worms, 
Table 6.  Sensitivity of the identified mutants to feeding RNAi targeting skn-1 and unc-22. 
Candidate gene Associated 
Alleles 
Sensitivity to skin-1 
dsRNA feeding 
Sensitivity to unc-22 
dsRNA feeding 
Asd-1 1026F - - 
1027E - - 
1103A - - 
1026G - - 
Asd-2 1026B + + 
1028G + + 
1029E + + 
Asd-3 1029C + + 
1031E + + 
1102B + + 
Asd-4 1025B + + 
1028F + + 
1029B + + 
Asd-5 1026A - - 
1031A - - 
1031F - - 
Asd-6 (rde-3) 1031B - - 
Asd-7 1028J + + 
Asd-8 1030D + + 
Asd-9 1026D + + 
Asd-10 1105A + + 
Asd-11 1030C + + 
rrf-1 1025A - - 
B09 - - 





as confirmed by visualization of green fluorescence after heat induction, I checked RNAi 
response in the resulting worms upon mCherry dsRNA ingestion (Fig 23C). I reasoned 
that mCherry dsRNA ingestion would lead to the silencing of mCherry expression in 
body wall muscle if the allele to be tested specifically disrupts antiviral RNAi but not 
classical RNAi. In contrast, no mCherry silencing should occur if the tested allele 
disrupts both classical RNAi and antiviral RNAi. I found that, as shown in Figure 24A 
and B, although enhanced FR1gfp replication was detected at comparable levels, 
mCherry silencing was observed in 11 worms (Fig 23C) containing alleles corresponding 
 
Fig 23. Results of feeding RNAi. (A) injection of unc-22 dsRNA at the concentration of 100 
ng/µl induced severe twitching phenotype in N2 and drh-1 but not in 11 worms carrying rde-4 
null allele and asd-1, asd-5, asd-6. (B) injection of unc-22 dsRNA at the concentration of 100 
ng/µl induced severe twitching in 11 worms containing alleles corresponding to asd-2, asd-3, 
asd-4, asd-7, asd-8, asd-9, asd-10, asd-11 and asd-12. (C) mCherry dsRNA ingestion would 
lead to the silencing of mCherry expression in body wall muscle if the allele tested 




to asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-11 and asd-12 but not for alleles 
corresponding asd-1, asd-5, asd-6. As a reconfirmation, I subjected the same set of 
worms to feeding RNAi test in which the target of RNAi were endogenous genes skn-1 
and unc-22. Again, as shown in Table 6, penetrating RNAi phenotype, manifested as 
dead eggs or twitching progenies, were observed in genetic alleles asd-2, asd-3, asd-4, 
asd-7, asd-8, asd-9, asd-10, asd-11 and asd-12 but not for asd-1, asd-5, asd-6. To rule 
out the possibility that the differential requirement of the identified genes in classical 
RNAi is an artifact associated with dsRNA feeding I tested the same set of worm mutants 
in RNAi response triggered by unc-22 dsRNA microinjection. As shown in Figure 23 A 
and B, injection of unc-22 dsRNA at the concentration of 100 ng/µl induced severe 
twitching phenotype in the progenies of injected N2 worms and 11 worms carrying drh-1 
null allele tm1329 and rrf-1 null allele ok589 but not in 11 worms carrying rde-4 null 
allele ne337. The same treatment induced strong twitching phenotype in progenies 
carrying alleles corresponding to asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-11 
and asd-12 but not in progenies corresponding to the rest of asd genes. These 





4.4 Some of the asd genes that are dispensable in classical RNAi do not confer resistance 
against Orsay virus 
To find out whether the identified genes are required for antiviral RNAi against Orsay 
virus, I checked Orsay virus infection in original mutants isolated from the genetic 
screen. To my surprise, I found that whereas enhanced Orsay virus replication was 
detected for all alleles assigned to asd-1, asd-2, asd-5, asd-6 and asd-9, such an 
enhancement in Orsay virus replication was not detected for alleles assigned to asd-3, 
asd-4, asd-7, asd-8, asd-10, asd-11 and asd-12. To rule out the possibility that random 
mutations in the original mutants may have inhibited Orsay virus replication in those 
mutants I checked Orsay virus replication in 11 worms that contain alleles corresponding 
to the asd genes. Again, enhanced Orsay virus replication was detected for alleles 
Fig. 24 Northern analysis of FR1gfp and Orsay virus replication of 12 asd mutant. (A) 
Northern analysis of FR1gfp in classical RNAi-related mutants. (B) Northern blot analysis of 
FR1gfp in antiviral dedicated mutants. (C) Northern analysis of Orsay virus replication in 




corresponding to asd-1, asd-2, asd-5, asd-6 and asd-9 but not for alleles corresponding to 
asd-3, asd-4, asd-7, asd-8, asd-10, asd-11 and asd-12 (Fig 24C). Since the latter set of 
asd genes do not contribute to classical RNAi, these results thus suggest that some of the 
asd genes that do not play important role in classical RNAi do not confer resistance to 
Orsay virus.  
 
4.5 Characterization of the candidate genes using Sanger sequencing 
To confirm the results from genetic complementation and to further characterize the 
candidate genes, Sanger sequencing was performed to examine the coding sequencing for 
rde-10, rde-11, rde-12, rde-2, rde-3, and drh-3 in the candidate mutants 1031A, 1031B, 
D03, D02 respectively. I chose these four alleles for further analysis mainly because they 
also disrupted classical RNAi pathway. rrf-1, rde-10, rde-11, rde-12, rde-2, rde-3 and  
 
Table 7. Candidate gene characterization by sequencing the coding sequences for known 






                                                                                                                                      
 
Fig 25. Sanger sequence data found (A) a G→A single nucleotide change in rrf-1 of 1025a. 
(B) a C→T single nucleotide change in rrf-1 of B09 and. (C) a G→A change from rde-3 of 




Fig 26. RDVI was restored in 11/1031B candidate mutant containing the extrachromosomal 
array generated. Injection of Psur-5::rde-3::UTR construct and Pmyo-2::mCherry reporter 
shown in Figure 26 restored antiviral RNAi in 11/1031B candidate mutant. Shown here is the 
visualization of mCherry and green fluorescence in the 11/1031B mutant that contain 
extrachromosomal arrays formed by the injected plasmids 24 hours post heat induction. There 
are three worms in the picture. The pictures showed the visualization of green fluorescence in 
1031B mutant with (red fluorescence in head) or without (no red fluorescence in head) an 
extrachromosomal array that contains Psur-5::rde-3::UTR and Pmyo-2::mCherry transgene 
array. The merged image was produced by merging images recorded under red and green 





drh-3 are known genes required for both antiviral and classical RNAi pathway. To find 
out whether any of my candidate alleles are derived from these genes I sequenced the 
coding regions corresponding to these genes in some of my candidates listed in Table 7. 
Please note that rde-12 is a novel gene which is important for antiviral RNAi and certain 
endogenous siRNAs. Its function is to produce secondary siRNA during the amplification 
process [136]. As expected, 1031B has a point mutation (G to A) in rde-3 ORF, causing a 
premature stop codon (Fig 25C). Alleles B09 and 1025A were also confirmed to have a 
single nucleotide base change at different position in rrf-1 ORF, causing a premature stop 
codon and a single amino acid change respectively (Fig 25A, B).  However, no genetic 
mutations were identified for other known RNAi genes in the candidate mutants 
sequenced. To confirm that the single point mutation in 1031B is indeed responsible for 
the loss of antiviral RNAi I delivered wild type rde-3 transgene into 1031B through 
gonad injection. As shown in figure 26, introduction of wild type rde-3 successfully 
restored antiviral RNAi in 1031B.  
 
4.6 Single molecule Fluorescent In-Situ Hybridization (smFISH) of C. elegans   
   In Fig. 24 B and C, I have shown that some of my candidate genes (eg.1028F, 1028J) 
are highly required for FHV resistance but are dispensable for antiviral defense against 
Orsay virus, indicating that these genes (1) may not specifically confer resistance to 





     In order to test this hypothesis, I developed a construct, named HIP::Orsay 
RdRP::UTR that contains Orsay virus RNA1 under the control of heat induced promoter 
(Fig 27B). The construct was used to transform 11/N2 and then was introduced into 
1028J, B01, 1028F and 3495 (drh-1) by genetic cross. Surprisingly, northern blot analysis 
detected robust Orsay virus replication in 1028J, B01, 1028F (Fig 27A), implying that 
1028J, B01 and 1028F are indeed involved in antiviral defense against Orsay virus. 
However, the accumulation level of Orsay virus in these mutants is still much lower 
compared to that in drh-1 mutants. Since transgene-mediated delivery of Orsay virus has 
bypassed the requirement of cell receptors for Orsay virus infection, this result suggests 
that candidate genes corresponding to B01, 1028F and 1028J may mainly function in the 
non-intestine tissue.  
To test the hypothesis that B01, 1028F and 1028J may have derived from genes that 
have tissue-specific function, I used single molecule fluorescent in situ hybridization 
(smFISH) strategy to identify the tissues where Orsay virus replicates in             
 
Fig. 27 (A) Northern analysis of Orsay virus replication in transgenic candidate mutants. 
Transgenic array containing Orsay virus RNA1 termed as 46 was integrated into N2 and 
introduced into 3495, B01 1028F and 1028J through genetic cross. RNA samples are 
extracted 24 hours after Heat induction of worms. (B) schematic structure of 46 transgene, 
which is composed of Heat-Induced Promoter at 5’ end, Orsay virus RdRP sequence and UTR 





   
Fig. 28 Cell localization of Orsay viral mRNA in C. elegans. (Left) 46/N2, JU1580, rde-1, 
R1D1(rde-1/drh-1), 46/3495, 11/46/B01, 11/46/1028J, 11/46/1028F mutants infected with 
Orsay virus were hybridized by 0.2nM probes which is conjugated with CAL Fluor Red 610 
(Biosearch Technology) and visualized by microscopy. All the worms were washed off 
from plates for fixation two days after Orsay virus infection. (Right) Heat-induced 46/N2, 
46/3495, 11/46/B01, 11/46/1028J, 11/46/1028F were hybridized by 0.2nM probes which is 
conjugated with CAL Fluor Red 610 (Biosearch Technology) and visualized by microscopy. 
All the worms (Except for the worms with intestine reporter) were washed off from plates 
for fixation one day after heat induction. Worms with intestine reporter are used to show the 
intestinal part in the worm body. This worm strain contains promoter that can drive 




mutants containing B01, 1028F or 1028J. smFISH method differs from conventional 
FISH by using many short oligos (20 base pairs long) to target different part of the RNA 
molecules. Each oligo is coupled with one fluorophore and thus is relatively faint. I 
combine multiple coupled oligos (48 oligos) together to produce a strong signal. By using 
different oligonucleotides, non-specific binding and false positive signal could be 
effectively reduced. The small oligos are also allowed to penetrate different tissue, 
yielding robust signal.  
    Previous study utilizing FISH has confirmed that Orsay virus mainly replicates in the 
anterior of intestine. My smFISH tests yielded similar results (Fig 28 Left) [137]. Clearly, 
as shown in Fig 28 Left, very small areas, or not at all, showed red fluorescence in 1028J, 
1028F and B01 mutants infected with Orsay virus in my smFISH tests. In B01 mutants, 
no red fluorophore was detected. However, in the transgenic 1028J, 1028F and B01 
mutants that contain the Orsay virus transgene, much larger fluorescent regions were 
observed. Interestingly, I found that Orsay virus can replicate in more intestinal regions 
(anterior or middle or posterior region) in the transgenic mutants (Fig 28 Right) 
compared to non-transgenic mutants infected by the virus naturally (Fig 28 Left). 
Considering the observation that Orsay virus can only replicate in intestinal cells in both 
transgene-derived and infection-derived condition (Fig 28), I believe that the elevated 
viral replication in broader areas is because the transgene approach delivered more 
viruses into the intestine cells. Collectively, the results indicate that the 1028J, 1028F and 
B01 candidate genes are expressed at high level in some of the non-intestine tissues and 





      In total, I have screened over 30 million of C. elegans mutants using an artificial virus 
as reporter for loss of antiviral RNAi. I expected to identify some genes dedicated to 
antiviral defense. The transgene array in the reporter strain has significantly reduced the 
time and workload for characterization of candidate alleles. In total I isolated 25 alleles 
which are assigned into 12 genes by genetic complementation tests (Table 5). I have also 
crossed candidate mutants with other known antiviral RNAi deficient mutants. Two of 
the candidate genes were identified as rrf-1 and rde-3, which were further reconfirmed 
through coding sequence examination (Fig 25). 
    rrf-1 encodes an RNA-dependent RNA Polymerase which contributes to the generation 
of 22G RNAs. rrf-1 modulates somatic cell gene expression through endogenous RNAi 
pathway. In addition, antiviral RNAi pathway has an amplification process which also 
requires rrf-1 for secondary 22G viRNAs biogenesis [7]. In the genetic complementation 
tests, I crossed 1025A and B09 with rrf-1 mutants and found that antiviral defense was 
not recovered in F1 progenies. In the Sanger sequence results, I found a G→A and a 
C→T single nucleotide change in 1025A and B09 respectively (Fig 25A, B) giving rise 
to a TGA and a TAG stop codon respectively.  
mut-2/rde-3 encodes a nucleotidyltransferase which is a member of the polymerase 
beta nucleotidyltransferase superfamily. A G to A nucleotide change was discovered at 
position 335 in rde-3 coding sequence in 1031B (Fig 25C), which caused an early stop 
codon. rde-3 is required for feeding RNAi but not for transgene-derived RNAi. Loss of 
RDE-3 function produces rde phonotype, indicating the importance of MUT-2/RDE-3 




of 22G RNAs implies that rde-3 is important for secondary siRNA amplification but less 
essential for primary siRNA production [111, 139, 140]. The function of rde-3 is not well 
understood. One tentative conclusion is that rde-3 may be implicated in the adenylation 
of mRNA, so aberrant transcripts without being processed by rde-3 could be degraded 
and compete for limited RNAi components, thus reducing the ability of cell to initiate 
RNAi. It is also possible that rde-3 may be involved in recruitment of RdRP in the 22G 
RNAi amplification process.  
Previously it has been shown that EMS mutagenesis mainly causes G to A or C to T 
single nucleotide change [17]. This is further confirmed in my genetic screen, in which G 
to A or C to T changes caused function loss for both rde-3 and rrf-1. These findings 
suggest that in future work on mapping and identification of unknown candidate genes, I 
should mainly focus on single nucleotide changes, such as G to A or C to T, especially 
those changes that give rise to stop codon and key amino acid change. This kind of 
changes in intron sequences should be ignored. Last but not the least, the multiple hits on 
a single gene such as rrf-1 and asd-1 suggest that my biased genetic screen had a good 
coverage on RDVI genes whose antiviral function can be compromised without affecting 
worm viability. 
    Surprisingly, I found that 7 of the candidate genes that specifically contribute to 
antiviral RNAi do not confer detectable resistance to intestine-infecting Orsay virus 
(Figure 24C). Previous study found that the tissue-specific infection pattern of Orsay 
virus remains unchanged, even when the virus replication is launched from a transgene 
transcriptionally active in non-intestine tissues. This observation suggests that it is a viral 




Orsay virus [113]. Orsay virus was originally identified in a wild C. elegans isolate 
defective in antiviral RNAi [3, 110, 141]. In laboratory setups, Orsay virus infects wild 
type N2 worms but only accumulates to low levels (Fig 24B, C), suggesting that Orsay 
virus has a weak, if at all, activity on RNAi suppression. This finding is in agreement 
with the hypothesis the replication of Orsay virus is significantly enhanced in RNAi-
defective mutants or in the presence of a viral RNAi suppressor [3, 7, 141, 142]. Since an 
activity on RNAi suppression is required for many viruses to establish successful 
infection [72], these observations support a hypothesis that some of those 7 candidate 
genes isolated from this work may function in a tissue specific manner thereby to prevent 
viruses other than Orsay virus from spreading out of the intestine tissue.  
The intestine is a primary organ in C. elegans that is composed of 20 cells in larvae 
and adults. It is important for nutrient absorption and macromolecule production [143]. I 
found that in Orsay virus-infected Ju1580 and rde-1 mutants, the red fluorescence was 
detected mainly in the anterior half of worm intestine (Fig 28 Left), indicating that the 
intestinal cells are differentially susceptible to virus infection and cells in the anterior half 
have relatively weaker antiviral activity. Interestingly there was no, or very weak, 
fluorescence observed in virus-infected asd mutants corresponding to B01, 1028F and 
1028J (Fig 28 Left), which support high level replication of FHV (Fig 24B). The smFISH 
data together with the northern blot data suggests that some of my candidate genes are 
weakly expressed in intestinal tissue but highly expressed in non-intestine cells. 
Non-allelic Non-complementation happens when two alleles from different gene loci 
fail to complement with each other for certain biological function. In this situation, the 




usually form a complex for functioning in the same pathway. This mechanism relates to a 
dosage-based scenario. Reduced dosage at both gene loci results in great reduction of 
dosage of the formed complex, leading to failure of complementation in certain pathway. 
For example, in C. elegans, mut-7 encodes an exoribonuclease, which forms a complex 
with RDE-2 required for efficient RNAi in vivo. In the genetic complementation test, 
only 50% of the MUT-7 is available for RDE-2, which is also reduced to 50% in 
heterozygous rde-2. As a result, only 25% MUT-7/RDE-2 is functional and it is not 
enough for efficient RNAi. Thus, genetic complementation may not be the final answer 
for the allele characterization. Therefore, some of the genetic alleles that were assigned to 
the same genes may actually be from distinct genes. Or in other words I might have more 
























CHAPTER 5: MAPPING AND IDENTIFICATION OF 




     Following forward genetic screen genetic mapping is done to locate chromosomal 
region harboring the mutation and search for the candidate mutations within the region. 
Typically, a genetic cross is performed between mutant of interest and a strain of the 
same species that carries genetic markers. 25% the second generation (F2) progenies from 
an F1 cross or self-cross inherit the mutation of interest in homozygous status. If the 
mutation is not dominant, or the wild type proteins from F1 parent can rescue the function 
of the mutated proteins, these F2 progenies with the mutations can be selected based on 
the phenotype. As a result, the markers for the mapping are randomly distributed in the F2 
progenies, except for the genetic markers that are genetically linked to the mutation. 
These linked markers which is physically close to the mutation are statistically less likely 
to be involved in recombinant events than the genetic markers that are distant from the 
target mutation. Therefore, the location of mutation will be revealed by the high 
frequency of genetic markers surround it.  
    In the past, the identification of genetic alleles is usually based on restriction fragment 
length polymorphism (RFLP) analysis, Amplified fragment length polymorphism 
(AFLP) or Short Tandem Repeat (STR) [144-146]. These techniques are widely used 
since they are inexpensive to use and easy to handle. However, owing to rapid 
development of the high-throughput sequencing technologies, these old techniques 




Whole Genome Sequencing (WGS) based on next-generation sequencing largely reduced 
the time and workload in mapping and identification genetic alleles.  
    WGS is the process that allows for acquiring the complete DNA sequence of the whole 
genome at one time. It is a fast and effective method to pinpoint the casual mutation 
caused by mutagenesis [147]. Compared to the reference genome, the mutagenized 
strains always contain some mutations that significantly influence the gene function. 
Therefore, it is very straightforward to map mutations to different loci in the genome and 
then determine which one is the phenotype-causing one [148].  
    In this study, when the candidate mutant with phenotype of interest is isolated, I 
crossed them with wild-type worm strain instead of strains with genetic markers. I did not 
use the only worm strain with genetic marker, the Hawaii strain, because it is naturally 
not resistant to virus. Therefore, if the candidate mutants were crossed with Hawaii strain, 
it would be impossible to isolate homozygous candidate mutant based on the phenotype. 
After crossing candidate strains with wild-type worms, the F2 progenies that carry 
homozygous mutations are selected. The F2 worms without the target mutation are used 
as control. Before the libraries are submitted for WGS, the genomic DNA is sheared into 
small fragments, approximately 350bp in length. The DNA fragments are then ligated 
with adaptor which contains index sequence. 
    After library construction, the worm genomic DNA will be sequenced on flow cell 
lane. The templates are immobilized on the flow cell surface that is coated with lawn, 
composed of oligos containing the sequence of adaptor. After the templates are 
hybridized to the oligos, the bridge amplification process is carried out. In this step, the 




polymerase generates the complementary strand and form double strand bridge. The 
bridge is then denatured, resulting in two single stand copies of template that are tethered 
to the flow cell. This process is repeated over and over to generate millions of clusters, 
leading to the clonal amplification of all the fragments. The reverse strands are then 
cleaved and washed away, leaving forward strands on the flow cell. The sequence begins 
with the extension of primer to produce reads. In each cycle, fluorescently labeled 
nucleotides compete for the addition to the nucleotide chain based on the sequence of the 
template. The clusters are excited by a light source after addition of each nucleotide and 
the characteristic fluorescent signal is emitted. This process is termed as Sequence-By-
Synthesis (SBS) [149]. Millions of clusters are sequenced simultaneously, and signals are 
collected. The entire deep sequencing process generates millions of reads for each 
fragment. These reads are separated based on their unique indexed adaptor. 
    The following data analysis is carried out in Linux environment hosted by HPC (High 
Performance Computing) at LSU. There has been much software developed for deep 
sequencing data analysis. The initial step of mapping the deep sequencing reads to a 
reference genome is alignment. In my project, I use Bowtie and BWA for short read 
alignment. The Sequence Aligned Map (SAM) text-based file is then generated. Next, the 
SAM file is processed using Samtools for sorting and indexing to generate Variant Call 
Format (VCF) file which contains the information of single-nucleotide polymorphism 
(SNP). At last I use GATK and SnpEff for SNP annotation and filtration to narrow down 
the mutation pool. In total we have successfully analyzed 3 libraries though HPC data 
analysis and for the first time identified mut-16 and rsd-6 as key components of worm 








5.2.1 The principle of mapping-by-sequencing strategy 
    Three candidate alleles, 1031A, D02, and D03, which are involved in classical RNAi 
and two candidates, B05 and 1029E which only contribute to antiviral immunity, were 
selected for libraries construction. Candidate mutants were crossed with 11/N2. One 
hundred F2s from the backcross were transferred to individual plates. At least 20 F2 
strains homozygous for mutant alleles were identified by scoring the segregation of the 
loss of antiviral RNAi phenotype in the F3 generation (Fig 29). The F3 populations from 
 
Fig 29. Schematic of Mapping-by-sequencing strategy. Hermaphroditic EMS mutants were 
crossed with male 11/N2. More than twenty F2 lines homozygous for the candidate alleles 
were selected for genomic DNA extraction. 11/N2 are allowed for self-fertilization and the F1 




candidate group were pooled for DNA extraction and library construction. 11/N2 worms 
were allowed to self-fertilize for the collection of reference genome sequence. The 
mutant phenotype was further confirmed at least two times to make sure the strains all 
contain homozygous mutant alleles. Random mutations originated from mutagenesis will 
be unbiased distributed in the F2 progenies except for those that are physically linked to 
the target mutation. Thus, I expect to see that random mutations are enriched in certain 
region in worm genomes that contain the target mutation during data analysis. 
 
5.2.2 Preparation of DNA library for whole genome sequencing 
    After the genomic DNA for each library was extracted following standard protocols 
(chapter 2.2.7), Bioruptor, at the setting of 15 secs on and, 90 secs off, was used to obtain 
small DNA fragments with sizes around 350bp. Then 10 µg from each pool was used for 
library construction. To construct libraries for sequencing, I choose PCR-free Truseq 
DNA kit (Illumina) to add adaptor and to perform size selection of DNA fragments. 
Index sequences for each candidate mutant are listed below (Table 8). Agarose gel 
Table 8. Index sequences for each library 











analysis and Bioanalyzer were utilized to check the quality of libraries. All the libraries 
were then combined in approximately the same amount and submitted to Biotechnology 
Center of University of Illinois for deep sequence (Fig 30).   
    Considering the high sensitivity of bioanalyzer, all of the DNA libraries were diluted 
1:5 with water. Only 1μl diluted DNA of each library was run on high sensitivity DNA 
chip. The charts (Fig 31 A-F) show size distribution of the six DNA libraries generated 
Fig 31. Size distribution for each genomic DNA library. Fig A-F are the bioanalyzer data 
from 11/B05, 11/N2, 11/1031A, 11/1027E, 11/1029E and 11/D03, respectively. The peaks in 
the chart represent the size (bp) and low signal intensity (F U) of the six sample libraries. 
 




by bioanalyzer. The major peaks are in range of 500-650, suggesting that the fragments in 
libraries are highly enriched at 550-600bp. The distribution of DNA fragment sizes is 
within the size range we expected after adapter ligation. 
    I also observed DNA smear in gel electrophoresis during library construction. Figure 
32A showed a distribution of DNA fragments after performing DNA shearing using 
Bioruptor sonicator. The fragment sizes are around 200-400bp. Figure 32B showed a size 
comparison between free DNA fragments and those from pair-end repair (lane 1, 2) and 
adapter ligation (lane 3-4). There was a clear increase in fragment size after adapter 
ligation.  
    Upon completing pair-end repair and DNA fragment size selection, the major size of 
DNA smear shifts from 350 to 450bp. After adapter ligation, The DNA fragments are 
 
Fig 32. (A) Gel pattern after DNA shearing of genome DNA for 15 min 45 secs (total time: 
15 secs” ON”, 90 secs “OFF”) using Bioruptor sonicator. (B) Gel pattern of DNA library 





highly enriched in region corresponding to 550-600bp, indicating that adaptors are 
successfully ligated to the DNA fragments (Fig 31, Fig 32).  
 
5.2.3 Whole genome sequencing through deep sequencing 
    The samples were multiplexed to have six libraries in one lane on flow cell for single-
read sequencing. The reads were generated at the size of 160nt on an Illumina 2500. The 
pool has been sequenced to produce over 181 million reads (Table 9) with near perfect 
quality scores. 
    The libraries were first quantitated by qPCR and then sequenced on one lane for 161 
cycles from one end of the fragments on a HiSeq 2500 using a HiSeq SBS sequencing kit 
version 4. 
    Fasta files were generated and demultiplexed with the bcl2fastq v2.17.1.14 conversion 
software (Illumina). 
Table 9. Number of reads generated for each library sequenced on an Illumina 2500 
1027E 1027E_GCCAAT_L001_R1_001.fastq 34,103,615 
1029E 1029E_CAGATC_L001_R1_001.fastq 40,675,540 
1031A 1031A_ACAGTG_L001_R1_001.fastq 26,295,574 
B05 B05_CGATGT_L001_R1_001.fastq 17,390,232 
D03 D03_CTTGTA_L001_R1_001.fastq 23,080,756 
N2 N2_TGACCA_L001_R1_001.fastq 39,730,386 






    FastQC was used to determine the quality of raw Fasta data. As shown in Figure 33, 
the reads generated from all 6 libraries produced very high-quality scores, which are 
around 36 points from the beginning of the sequence through to the end. Therefore, 
further trimming is not necessary for these Fasta files. 
 
5.2.4 Deep Sequencing Data Analysis 
5.2.4.1 The pipeline for sequencing reads analysis 
    Genome resequencing is applied to achieve at least 30x coverage of the reads. The 
causal mutation was identified by interrogating the whole-genome resequencing data 
from each base-pair of wild type and mutant pools used. As shown in Fig 35, at the first 
step, I used bowtie and BWA to align 160bp DNA reads to the reference sequence to 
Fig 33. Per base sequence quality of each library. This graph shows the quality of each base at 
each position in the reads. The Y-axis on the graph shows the quality score, the higher the 
score the better. The X-axis on the graph represents the base position. The red line in the 
yellow box represents the median value of score. The Yellow box represents the inter-quartile 




create a SAM file, which is utilized to store biological sequences aligned to reference 
sequence. The major differences between BWA and Bowtie are the speed of alignment 
and sensitivity. BWA counts occurrences and provides mapping quality, making it more 
than four times slower than Bowtie. However, BWA yields more valid matches than 
bowtie though the differences are not significant. In other words, BWA has relatively 
higher sensitivity. Therefore, I used both of them for comparison and reconfirmation.  
Next, I used Samtools to sort and index the aligned sequences and generate VCF files 
that can be used to store the information of the SNPs or indels or Frameshift mutations 
compared to reference genome. To deal with alignment sequences, the first step is to 
convert SAM file to its binary format, the BAM file, since the binary format is easier for 
computer programs to work on. However, the BAM file generated from Fasta files are in 
random order with regard to their position in the reference genome. In order to make it 
easier to manipulate, the file must be sorted so that the alignment sequences can display 
in “genome order”. That means the sequences are ordered based on the position of each 
genome. Another important procedure before generating VCF file is indexing. Indexing 
 
Fig 34. Schematic representation of Strategy to analyze deep sequence data. All the Fasta data 
were aligned to WS235 reference by Bowtie/BWA to generate SAM file. The Aligned 
sequences are then sorted, merged, and indexed by Samtools to produce VCF. Two software 




the sorted BAM file allows for quick extraction of alignment sequences in particular 
genome region. Then Samtools “mpileup” command was used to generate variant data by 
comparing between the reference sequences and sorted alignment file. For example, to 
obtain e the VCF file of D03 library, we use the following command line: 
    The command line means the sorted D03 bam file (D03.sort.bam) was compared with 
reference genome (C. elegans genomeWS235.fa) to generate BCF file for D03. BCF is 
the binary version of VCF file. Other options such as -uf or -bvcg are used to determine 
the input or output format of the files. 
    In the end, after converting BCF to VCF file, the VCF file was annotated and filtered 
to extract the information of interest. The modified VCF file can show how much impact 
each SNP or INDEL could bring to the mutated genes (Fig 34). In my study, I mainly 
focus on SNP since it is the major mutation type that EMS causes. In addition, I narrowed 
down the candidate SNPs unique to the mutant pool by identifying those mutations 
featuring a G to A or C to T change. The SNPs that can cause early stop codon or 
important amino acid change are of top priority for further analysis. Subsequently, I 
created VCF file for each mutant and wild type library. SNPs from each candidate library 
except the mutation of interest were subtracted using SNPs from wild type as reference, 
which further reduced the number of variants that need to be characterized. 
 
5.2.4.2 Identification of mut-16 and rsd-6 as key antiviral RNAi genes  
    Several candidate genes were picked up for further analysis based on the impact of 
corresponding SNPs on their function. I also used feeding RNAi as complementary 




found that missense mutations usually are much less likely to be the mutations I was 
looking for compared to the mutations that totally caused premature stop codon in the 
coding sequence. Hence, I started to work on mutations with high impact on the gene 
function, such as the mutations that cause stop codon or frameshifting event. 
    Eventually, I mapped D02 and D03 to B0379.3 on chromosome I, which encodes mut-
16. 1031A was mapped to F16D3.2 on the same chromosome I, which encodes rsd-6. 
The mutations for each allele was confirmed by Sanger sequencing (Fig 35, 37). Thus, 
these efforts identified mut-16 and rsd-6 as the key genes required for antiviral RNAi 
respectively.  
 
Fig 35. Sanger Results of sanger sequence for mut-16 on 1027E, D03, D02 and 1103A. (A) A 
G→ A SNP is found in mut-16 of 1027E at position 1635. (B) A C→ T SNP is found in mut-
16 of D02 at position 2215. (C) A C→ T SNP is found in mut-16 of D03 at position 2284. (D) 




MUT-16 was not known to be required for antiviral RNAi defense. In previous study, 
MUT-16 was found to be  a worm-specific protein that plays important function in 
WAGO 22G RNA pathway [140]. It is required for both somatic and germline RNAi. 
Loss of MUT-16 results in depletion of ERGO-1 class 26G RNAs and 22G RNAs, but 
not ALG-3/4 class 26G RNAs [97], suggesting an important role in endogenous RNAi 
[150]. Some other studies also showed that MUT-16 recruits MUT-2, MUT-7, and MUT-
15 to form Mutator foci in germline for WAGO 22G RNA amplification and target 
silencing [151]. In my study, two null alleles of mut-16 (D02, D03) containing early stop 
codon at position 10081968 and 10083376 were identified on chromosome I, respectively 
(Fig 35B, C). Another two mut-16 alleles, 1027E and 1103A which were assigned to the 
same candidate gene asd-1 through genetic complementation tests, were also confirmed 
by Sanger sequence (Fig 35A, D). As shown in Fig 35A, a G→ A transition, which 
 
Fig 36. FR1gfp can replicate in 11/N2 after feeding with dsRNA of a sequence from mut-16. 
Visualization of green fluorescence in 11/N2 worms subjected to feeding RNAi targeting mut-
16. There are four worms in the picture, left two worms are subjected to feeding with mut-16 
dsRNA and right two worms are fed with regular OP50 bacteria. Photographs were taken 24 




results in an important amino acid change from Asp→Asn, was found in 1027E at 
position 532. A C→A base change was found in mut-16 of 1103A at position 723 (Fig 
35D), causing an early stop codon. As reconfirmation, I introduced a wild-type mut-16 
transgene driven by a sur-5 promoter into D02 mutant. As a result, the antiviral function 
in the transformed D02 worms is rescued. In addition, I selected a unique DNA sequence, 
which is 452bp in length, in mut-16 for the construction of a plasmid to be used in 
feeding RNAi. Then 11/N2 wild type worms were fed with bacteria engineered to 
produce mut-16 dsRNA. As shown in Fig 36, the replication of FR1gfp is restored when 
the function of mut-16 is specifically down-regulated. All these results thus confirmed 
that asd-1 is mut-16.  
A C to T transition at position 8359112 on chromosome I caused a premature stop 
codon in 1031A (Fig 37A), an rsd-6 allele which was assigned to asd-5 in our genetic 
complementation test. The other two alleles of asd-5 were also analyzed by Sanger 
sequencing. Similarly, a C to T change was identified in rsd-6 coding sequence in 1026A 
(Fig 37B). A G to A change was identified in 1031F (Fig 37C). The fact that all three 
 
Fig 37. Sanger Results of Sanger sequence for rsd-6 on 1031A, 1026A and 1031F. (A) A 
C→T SNP is found in rsd-6 of 1031A at position of 290nt. (B) A C→T SNP is found in rsd-6 






mutation changes caused premature stop codon in rsd-6 open reading frame strongly 
suggests that my candidate gene asd-5 is rsd-6.  
    Previously, rsd-6 was found to be required for RNAi activity in the germline [96]. The 
protein that is most frequently found to interact with RSD-6 is RSD-2 [96]. BLAST 
analysis shows that RSD-6 contains a Tudor domain, a structure frequently found in RNA 
binding proteins although itself is not believed to be an RNA binding motif. This 
observation suggests that RSD-6 may be able to bind  RNA [152]. Since rsd-6 mutants 
are resistant to skn-1 and unc-22 dsRNA feeding, I believe RSD-6 plays an essential role  
Fig 38. RDVI was restored in 11/1026A mutant containing the extrachromosomal array 
generated through gonad injection. Injection of Psur-5::rsd-6::UTR construct and Pmyo-
2::mCherry reporter shown in Figure 38 restored antiviral RNAi in 11/1206A candidate 
mutant that contain FR1gfp transgene and Pmyo-3::mCherry reporter. Shown here is the 
visualization of mCherry and green fluorescence in the 11/ 1026A mutants that contain 
extrachromosomal arrays formed by the injected plasmids 24 hours post heat induction. There 
four worms in the picture, which showed the visualization of green fluorescence in 1026A 
mutant with (red fluorescence in head) or without (no red fluorescence in head) an 
extrachromosomal array that contains Psur-5::rsd-6::UTR and Pmyo-2::mCherry transgene 
array. The merged image was produced by merging images recorded under red and green 





in classical RNAi. To reconfirm that the loss of antiviral RNAi in worm mutants 
containing rsd-6 alleles are indeed a result of RSD-6 function disruption, I delivered wild 
type rsd-6 transgene driven by the sur-5 promoter (Psur-5::rsd-6::UTR) into 1026A 
mutants containing the FR1gfp viral replicon. As shown in Fig 38, GFP expression was 
abolished in the transformed worms that contain the Psur-5::rsd-6::UTR transgene, 
indicating that the rsd-6 alleles is indeed responsible for the loss of antiviral response in 





      In principle, random mutations generated during mutagenesis should be randomly 
distributed in the F2 progenies except for those that are closely to the target mutation. 
Therefore, the target mutation can be easily identified by searching the genomic regions 
in which the random mutations are enriched. However, when I used this strategy for 
target mutation identification such regions that contain enriched random mutations were 
 
Fig 39. Schematic presentation of new strategy for Mapping-by-sequencing. Hermaphroditic 
EMS mutants cross with male 11/N2. F2 progenies are transferred into individual petri dish 
for growth. We select at least fifty F2 candidate mutants as target mutant library and at least 
fifty F2 wild type worms as control library by scoring the segregation of GFP in the F3 
progenies after heat induction. All the F3 from selected F2 mutants are collected as the pool of 
candidate library for subsequent DNA extraction. All the F3 from selected F2 wild type are 





not spotted during our initial analysis. I believe that this is partly due to the fact that EMS 
mutagenesis under my experimental condition did not yield a large number of random 
mutations around our target mutations. And this is the major reason that I cannot pick up 
mutations of interest from B05 and 1029E candidate libraries. Therefore, alternative 
strategy will be needed for our target mutation identification. 
    Figure 39 illustrates an alternative strategy for mapping-by-sequencing, which can be 
used in our future work. In this strategy, two genomic DNA libraries, a candidate library 
and a control library, will be constructed for deep sequencing. The candidate library will 
be constructed for the F2 populations that contain the target mutation and random 
mutations and the control library will be constructed for the F2 populations that may 
contain the same set of random mutations but not the target mutations. After deep 
sequencing and VCF file generation the target mutation together with closely linked 
random mutations can be easily identified by removing other random mutations that are 
shared between these two libraries. This is a free software package that can be used to 
remove the shared random mutations through a subtraction operation. The new mapping-
by-sequencing strategy is expected to significantly reduce the time and workload for 
target mutation identification     
      Success in sequencing the whole genome of an organism depends relies on the quality 
of the genomic DNA library to be used for deep sequencing.  Currently there are two 
major strategies used for genomic DNA library construction: one is PCR amplification-
dependent and the other is not. Before the success in sequencing some of my candidate 
genomes, I also tried PCR-dependent protocol. This PCR-dependent method consists of 2 




DNA. Then limited-cycle PCR cycles were carried out to extend the fragments to full-
length dual-indexed libraries (Fig 40). In my experience this method tends to produce 
broader size range of the DNA fragments, which may be generated in the PCR 
amplification step.  
    Using an in-house developed pipeline, I have successfully analyzed 3 sets of deep 
sequencing reads generated for my candidate genomes. This effort has led to the 
identification of 4 mut-16 alleles (D02, 1026g/D03, 1103a and 1027e) and 3 rsd-6 alleles 
(1026A, 1031A and 1031F) (Fig 35, 37). The D03 allele was not assigned to asd-1 during 
the genetic complementation analyses. The D03 worms have severe developmental 
defects, namely slow growth and small brood size, and as such very few F1 worms were 
produced after cross, making it hard to perform statistical analysis. 
    mut-16 is an important gene involved in biogenesis of 22G RNAs in the ERGO-1 
pathway [139]. This observation suggests that mut-16 may have a role in maintaining the 
 
Fig 40. Schematic of double index 2-step library method. Input DNA fragments are attached 
with Y-yoke stubs. Limited cycle PCR is used to add indexes and extend adapters to DNA 




function of secondary 22G viRNA in antiviral RNAi pathway [140]. In my study, I also 
noticed that loss of mut-16 function results in abnormal physiological characteristics such 
as reduced brood size, temperature sensitivity and abnormal morphology (Table 5), 
indicating its role in endogenous RNAi. Currently exactly how mut-16 contributes to 
antiviral RNAi requires further studies.  
    rsd-6 is predicted to contain a Tudor domain orthologous to TDRD5 in mammals. It is 
known that Human TDRD5 is involved in repression of transposable elements and is 
essential for germline integrity. Currently how rsd-6 function contributes to antiviral 
activity remains largely unknown. The following 3 observations suggest that rsd-6 may 
maintain germline integrity by promoting the synthesis of secondary siRNAs under some 
unfavorable environments: First, the expression of rsd-6 is environmentally regulated. 
Second, rsd-6 contributes to germline cell, but not somatic cell, development by 
promoting secondary siRNA biogenesis. And third, RSD-6 and RSD-2 proteins form a 
complex to promote RNAi spreading from somatic cells to germline cells [153-155]. In 
my study, I found that all rsd-6 alleles confer resistance to RNAi triggered by feeding or 
injection of dsRNA in both body wall muscle cells and intestinal cells (Table 6, Fig 23). 
This finding suggests that rsd-6 is required for RNAi response in somatic cells. 
Considering the function of Tudor domain, I propose that RSD-6 may promote the 
biogenesis of secondary viRNAs by binding to primary viRNAs or it may facilitate the 
interactions between proteins involved in secondary viRNA amplification. 
    Through genetic complementation tests, cDNA sequencing and whole genome 
sequencing I have confirmed that no rsd-2, drh-1, rde-1 or rde-4 alleles have been 




together with the reporter viral replicon indeed makes it possible to automatically reject 
genetic mutations associated with known antiviral RNAi genes during genetic screen. 





































CHAPTER 6: GENERAL DISCUSSION 
    Antiviral mechanisms are essential for all cellular creatures to survive. Cellular 
organisms have evolved diverse antiviral mechanisms to protect them from viral 
infection. In worms, insects and plants, RNAi is known as the major innate antiviral 
mechanism to defend off virus attack. However, in mammals, the interferon (IFN) 
response of innate immunity is defined as the most important innate antiviral mechanism. 
In mammalian cells, virus-derived dsRNA can be recognized by pattern recognition 
receptors (PRRs) such as Toll-like receptors (TLRs). Once the TLR-dependent pathway 
is activated, the production of  type-I IFN will ensue [156]. Another group of PRRs is the 
so-called RIG-I-like receptors (RLRs). RLRs are able to detect cytoplasmic dsRNA 
derived from virus replication [157]. All these receptors can detect the common viral 
structures termed pathogen-associated molecular patterns (PAMPs) such as dsRNA 
produced by replicating virus [158]. In addition to IFN, some studies also demonstrated 
that antiviral proteins induced by viral dsRNA become associated PKR [159]. These 
different antiviral pathways likely work together to enable a synergistic antiviral effect. 
In the recent years, several studies have argued that RNAi has direct antiviral role in 
mammalian cells [9, 160]. This point of view is based on the observation of accumulation 
of virus-specific siRNA in different genetic backgrounds. However, the involvement of 
interferon-mediated innate antiviral responses always complicates the situation since 
siRNA is also the trigger of IFN response. Since miRNAs regulate the expression of 
many interferon stimulated genes it is also possible that the increase of viral replication 
observed in RNAi-deficient mammalian cells could be due to the loss of cellular miRNA 




antiviral mechanism in mammalian cells still remains to be resolved. C. elegans as a 
model organism has many homologous genes to human. For instance, C. elegans drh-1 is 
a homolog of human RIG-I-like helicase gene, which functions in the detection of RNA 
virus [3]. My study is expected to pick up some mammalian homologs with antiviral 
function in C. elegans through genetic screen. Because IFN response does not exist in the 
worm system, study of the worm homologs could bring us a better understanding on how 
human antiviral genes work. My study may also facilitate addressing question whether 
antiviral RNAi plays a major role in mammalian antiviral defense. 
    RNAi is a post-transcriptional gene regulatory mechanism initiated by double-stranded 
RNA, including viral dsRNA. The RNA virus, usually single-stranded, can form dsRNA 
during replication process, and thus serves as trigger for RNAi response. RNA viruses are 
very dangerous to all kingdoms including mammals. More importantly, some of them are 
very hard to destroy by the adaptive immunity because of two major reasons. First, RNA 
viruses generally have much higher mutation rate compared to DNA virus because of the 
lack of proof-reading ability in their replicase. Second, RNA viruses have mechanisms of 
re-assortment and recombination for their genome to evolve faster [161-164]. However, 
since viRNAs are directly processed from viral dsRNAs, making it almost impossible for 
virus to escape the targeting of RDVI by mutating their genome. This explains why viral 
infection caused diseases are often the result of perturbation of host RDVI by a viral 
RNAi suppression.   
    RNAi has been successfully used to inhibit the replication of several human pathogens 
including human immunodeficiency virus type 1, hepatitis C virus, hepatitis B virus, 




RDVI holds the promise to develop novel antiviral strategies. To date, several research 
groups have demonstrated that RDVI can be initiated in undifferentiated mammalian 
cells and protects developing mice from the attack of lethal viral pathogen [9, 160, 166]. 
This discovery suggests that findings from RDVI studies may lead to the development of 
novel therapy for human diseases caused by viral infection.  
    Artificial dsRNAs trigger potent RNAi response in diverse organisms. It has been used 
to study the core mechanism of RNAi in many labs. These studies so far have identified 
several classes of genes, such as Dicer, Argonaut and RdRP as key components of RNAi 
[107, 167, 168]. Mechanistic studies of these genes have significantly improved our 
understanding on the core mechanism of various RNAi responses, including RDVI. 
However, since none of these factors are identified in RNAi response triggered by virus, 
it has remained to be a very interesting topic to ask to what extent RDVI shares key 
factors with other RNAi pathways.  
In this project, I have successfully developed a unique reporter strain by co-delivery of 
four known antiviral RNAi genes and a viral reporter gene into wild-type N2 worms (Fig 
13). After these transgenes were injected into the worm gonad (Fig 11), they were 
expected to form a large extrachromosomal DNA array in which each transgene has 
multiple copies. I expected that when a worm strain containing this transgene array is 
used for genetic screen the chance for mutagen to completely inactivate any of these 4 
antiviral RNAi genes will be extremely low. Indeed, when I used genetic 
complementation analysis combined with cDNA sequencing and whole genome 
sequencing to characterize my candidate alleles, none of them were found to have derived 




RNAi genes indeed significantly expedites my gene discovery process. Transforming 
worms with a combination of many target constructs can be done in any labs with basic 
worm transformation facilities. Thus, this strategy can be adopted to discover genes in 
other biological pathways in the worm systems.  
      Interestingly, 7 of my candidate genes appeared to confer antiviral function 
specifically against FHV but not Orsay virus (Fig 24B, C). Orsay virus is known to 
specifically infect intestine cells in C. elegans. These observations together suggest that 
those 7 candidate genes may mainly function in the non-intestine cells and as such their 
antiviral activity cannot be detected during Orsay virus infection. To test the hypothesis, I 
used smFISH technology to detect Orsay virus genomic RNAs in the infected candidate 
mutants. Indeed, I could only see weak viral replication in the anterior part of the 
intestine in some of the candidate mutants (Fig 28 Left). To further confirm this result, I 
delivered Orsay virus into the candidate mutants using the transgene strategy, which 
would have bypassed the requirement of cell receptor for Orsay virus to gain cell entry 
(Fig 27B). Again, weak viral replication was detected only in some of the transgenic 
mutants that carry the Orsay virus transgene (Fig 28 Right). Interestingly, the transgene-
derived Orsay virus seems able to infect more intestine cells, including cells in the 
posterior part of the intestine (Fig 28 Right). However, since the overall viral replication 
level is increased in the transgene-mediated viral inoculation I believe that the detected 
enhancement of viral replication in posterior intestine cells is mainly because more 
viruses are introduced into the cells when transgene strategy was used for virus delivery. 
Previously it has been noticed that although the heat inducible promoter that drives the 




higher in the intestine cells, suggesting that the intestine cells are naturally less resistant 
to viral infection. It is therefore likely that those 7 candidate genes mainly function in the 
non-intestine cells to confer antiviral resistance. 
    Some mammalian genes also function in a tissue-specific manner. For example, 
approximately 7835 human proteins exhibit a significantly increased expression level in 
some tissues. With regard to antiviral genes, it was discovered that some IFN-stimulated 
genes, such as ISG54 and ISG56, were also found to be expressed in a tissue-specific 
manner [169]. Some studies demonstrated that the chicken homologues of  interferon 
regulated genes (IRGs) also have a highly tissue specific and time specific expression 
pattern as their expression level are distinct between spleen and lung over time [170]. 
These observations together suggest that tissue-specific gene plays an important role in 
metazoan biology, and they are the major factor that affects the outcome of virus 
infection. Apparently, the identification of tissue-specific antiviral genes in C. elegans, if 
reconfirmed in our future study, makes it possible to study their function and mechanism 
in a model organism. Findings from this study may have important input to study of 
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